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Abstract
A detailed mathematical description of all the processes in a cell could be an
informative tool for investigating biological function. Detailed kinetic mod-
els could be built either by obtaining enzyme kinetic parameters in vitro, or
by obtaining them from time series analyses of metabolite data from rapid
pulse experiments. A genome scale in vitro enzyme kinetic assay project
would be prohibitively laborious with the current technologies. Further,
there are still uncertainties about the importance of in vivo effects such as
metabolite channelling, spatial effects and molecular crowding which could
make in vitro determined parameters invalid. Accordingly, there is much
interest in in vivo experiments for kinetic modelling. In vivo experimental
methods suffer from a number of technical and even fundamental problems.
Technical problems are being solved by more sensitive metabolomics tools
and rapid sampling technologies. However, the large number of effectors of
each enzyme reaction makes it impossible to obtain models at the level of de-
tail possible with the in vitro method. Ultimately, the solution to building a
genome scale Silicon Cell is to make use of both strategies. As metabolomics
technologies are rapidly improving, it would thus make sense to follow the
parts-based in vitro kinetics methodology, and carry out a detailed accuracy
assessment of the model with in vivo experiments. To address the problem
of the fundamental limit of information from concentration time-series, other
in vivo experiments will have to be carried out as well. 13C-metabolic flux
analysis has recently undergone vast improvements with the use of better ex-
perimental protocols and powerful algorithms for flux calculation. Incorpo-
ration of this type of experiment in the validation protocol is the aim of this
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thesis, which represents an intermediary step towards using the genome-scale
stoichiometric models as platforms for building genome-scale kinetic mod-
els. It is illustrated here how kinetic models can be combined with metabolic
flux data in a special way which allows correct modelling of boundary con-
ditions and validation using novel concepts. We used 13C-metabolic flux
analysis and gas chromatography-mass-spectrometry to measure metabolic
fluxes through the central metabolic pathways of the yeast Saccharomyces
cerevisiae. This data was integrated with a previously constructed detailed
kinetic model of fermentative glycolysis in the yeast to illustrate our ap-
proach. Various implications for such data integration with kinetic models
were identified and a software program was designed for this purpose.
Opsomming
’n Gedetailleerde wiskundige beskrywing van al die prosesse in ’n sel kan
’n kragtige middel wees vir die bestudering van biologiese funksies. Gede-
tailleerde kinetiese modelle kan gekonstrueer word vanaf ensiem kinetiese
parameters soos bepaal in vitro, of deur dit te verky met tydreeks analise
van metaboliet data vanaf puls eksperimente. ’n Genoom-skaal in vitro en-
siemkinetika projek sou te werksintensief wees met die huidige tegnologiee¨.
Verder is daar nog onsekerhede oor die belangrikheid van in vivo faktore
soos metaboliet kanallering, ruimtelike faktore en molekuleˆre verdringing
wat in vitro parameters ongeldig sou kon maak. Gevolglik word daar baie
belang gestel in in vivo eksperimente vir kinetiese modellering. In vivo
eksperimentele metodes ly onder ’n aantal tegniese en selfs fundamentele
probleme. Tegniese probleme word oorbrug deur ontwikkeling van meer
sensitiewe metaboloom tegnieke en vinnige monstering. Heelaas maak die
groot aantal affektore van elke ensiemreaksie dit onmoontlik om modelle
met dieselfde vlak van detail te verkry as wat moontlik is met die in vitro
metode. Gevolglik is die oplossing to die konstruksie van ’n genoom-skaal
Silikon Sel dat beide strategiee¨ gevolg moet word. Aangesien metaboloom
tegnologiee¨ tans vining verbeter, maak dit dus sin dat die deelwyse in vitro
metode te gebruik, gevolg deur gedetailleerde akkuraatheids assessering van
die model met in vivo eksperimente. Om die fundamentele limiet van in-
formasie vanaf konsentrasie tydreeks data te oorbrug moet ander in vivo
eksperimente ook uitgevoer word. 13C-metaboliese fluksie analise het on-
langs groot verbeteringe ondergaan met die gebruik van beter eksperimentele
protokol en kragtige algortmes vir fluksie berekeninge. Inkorporering van
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hierdie tipe eksperiment in die valideringsprotokol is die doelwit van die tesis,
wat ’n intermedieeˆre stap voor die gebruik van genoom-skaal stoichiome-
triese modelle as platforms vir die bou van genoom-skaal kinetiese modelle
voorstel. Dit word hier gewys hoe kinetiese modelle met metaboliese fluks
data gekombineer kan word in ’n spesiale manier wat modellering van rant
kondisies toelaat, asook validering op grond van nuwe beginsels. Ons het
13C-metaboliese fluksie analise an gas chromatografie-massa-spektrometrie
gebruik om fluksies te meet deur die sentrale metaboliese wiee¨ van die gis
Saccharomyces cerevisiae. Hierdie data was gekombineer met ’n voorheen
gekonstrueerde kinetiese model van fermentatiewe glikolise in die gis om die
tegniek te illustreer. Daar is klem gele¨ op verskeie implikasies vir sulke data
integrering met kinetiese modelle en ’n sagteware program was ontwerp vir
hierdie doel.
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"Progress in science depends on new techniques, new discoveries
and new ideas, probably in that order."
Sydney Brenner, Nature, 5 June 1980
Preface
In our age it has become very important to understand biochemical processes
in terms of mathematical models that can capture their nonlinear and com-
plex behaviour. Various approaches have been used to describe parts of a
living cell - enzyme kinetic models, stoichiometric models, fuzzy logic and
cybernetic models. Eventually, we would like to build large models that
can describe a complete cell, incorporating all levels of regulation. Some
have pointed out that the marriage between enzyme kinetics, stoichiome-
try and genetic regulation can be a detailed mechanistic one only in the
high-information future, while we now have to use cybernetics and fuzzy-
logic to reach practical applications [1, 2]. We agree that detailed kinetic
modelling of the parts is difficult and that it is very ambitious to model a
complete organism at this stage. However, the recent advances in analyti-
cal technology allow a more data rich process. It is argued that improved
measurement techniques, especially those for estimation of metabolic fluxes,
can now assist in a detailed kinetic modelling process of the cell.
The Silicon Cell Initiative is our long-term goal, which is aimed at a de-
tailed kinetic model of a cell. Instead of trying to create a genome-scale
model by starting with cybernetic or fuzzy modelling and working towards
more detail, our starting point is a detailed bottom-up approach, while the
system boundaries are well-characterized for the reference conditions with
experimental data. This approach involves combining of kinetic models with
larger, but static stoichiometric models. In essence, the larger stoichiomet-
ric model is used as a data model for calculating metabolic fluxes, and it
is connected to the kinetic model only through a set of measured bound-
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ary reactions. We focused on experiments using 13C-metabolic flux analysis
(13C-MFA) for it provides very detailed flux data. The aims of this thesis
are:
1. To learn the techniques in 13C-MFA.
2. To investigate how the boundary reactions should be incorporated for
steady state kinetic modelling.
Before our detailed discussions from Chapter 3 onwards, we start with an
overview of the most relevant principles in systems biology in Chapter 1.
These are set in the perspective of a rapidly changing scientific world char-
acterized by large-scale data acquisition technologies (the ’omics’) and in-
formation databases, and how some fields of systems biology are striving
towards harnessing the information content. It is argued that strong ele-
ments of omics and bioinformatics should be incorporated into the mod-
elling process of a Silicon Cell. Without the practicality that these elements
provide, I suspect that large-scale detailed kinetic modelling will merely re-
main a goal for very long. Further, these elements will ensure that success
in the outcome - a satisfactory description of a model organism - will not
only be applicable to the model organism. These elements will help to de-
velop a generic protocol for building genome-scale kinetic models, and allow
application to many real-world problems.
While Chapter 1 is an introduction to some of the relevant themes in current
systems biology and discusses some principles that are not directly used in
our study, such as flux balance analysis, Chapter 2 is a technical introduction
to the main principles of 13C-MFA. In our flux-constrained kinetic modelling
approach, 13C-MFA and kinetic modelling (discussed in Chapter 1) are the
main principles used. Chapters 1 and 2 thus together form the bulk of our
literature study.
In Chapter 3 we discuss how incorporation of boundary fluxes is in principle
necessary to obtain a realistic assessment of the accuracy in the modelled
kinetics. It is also explained that 13C-MFA experiments can yield interesting
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information that can be applied in a more detailed assessment of model
accuracy, to be used in combination with dynamic pulse experiments. Based
on these findings we describe a software program called Kinomics that we
created for this flux-constrained modelling regime (Chapter 4).
To illustrate our approach we measured metabolic fluxes in the yeast Saccha-
romyces cerevisiae at a quasi steady state with 13C-constrained flux balanc-
ing, using gas chromatography-mass-spectrometry (GC-MS) and the anal-
ysis program FiatFlux (Chapter 5). Our program was then used to constrain
a detailed kinetic model of yeast glycolysis with the flux data from our ex-
periments (Chapter 6).
Apart from the specialized method development for the combination of ki-
netic modelling and flux analysis, this work can be seen as a starting point
to further multidisciplinary studies in the context of the Silicon Cell.
Chapter 1
Systems Biology, Omics, and
the Silicon Cell
In the current era of ’functional genomics’, the meaning of ’genomics’ has
changed somewhat from the study of DNA and the genes that it contains,
to the wider meaning of studying biological components at the genome-
scale. What has caused this shift in meaning, is the strong emphasis on
large-scale data acquisition which drives the continued technological break-
throughs in the omics fields. The result is that complete genomes can rapidly
be sequenced and a vast array of high-throughput technologies has become
available for observing thousands of cellular components at once. Of these,
microarray technologies for observing the RNAs present are perhaps the best
known of all. Usually, these omics are used in a fashion where the profile of
a certain experimental state of importance, like a disease state, is compared
to that of the normal state. Statistical methods are then used to identify
components of which their presence or abundance is in some way corre-
lated to the characteristic behaviour. Unfortunately, exploration of data in
a purely statistical manner does not give deep insight into the workings of
a biological system. The nonlinear and complex behaviour of biochemical
systems necessitates an understanding in terms of mechanistic models that
capture the nature of these systems.
One characteristic aspect of the omics is the remarkably effective techniques
1
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for identifying, and in some instances quantifying components, but an in-
ability to provide the kinetic features of reaction networks. That is, how
fast are components interconverted (metabolism), how fast do components
activate or inhibit one another (signal transduction) and how fast are they
synthesised de novo and broken down (all macromolecules). These kinetic
aspects hold useful information to explain the observed component patterns
of the omics. This need for kinetic data types is becoming increasingly evi-
dent and significant effort has gone into the calculation of metabolic fluxes.
Metabolic Flux Analysis (MFA) is now seen as an important form of data
for integrated functional genomics to complement the proteomics and tran-
scriptomics [3].
MFA uses models which are based on stoichiometry. The stoichiometry
of a metabolic network is thus the first type of model that we can use to
relate data to a deeper understanding of the phenotype. Stoichiometric
models can be used in a number of related frameworks, of which metabolite
balancing, flux balance analysis (FBA) and genome-scale network models
are discussed in the first few sections of this chapter, while stable isotope
based flux analysis is discussed in more detail in Chapter 2.
1.1 Metabolite balancing
Metabolite balancing is based on the assumption that mass is conserved in a
metabolic system at a steady state. The steady state is the condition where
there is mass flow through a metabolic system but the metabolite concen-
trations do not change over time. A set of metabolite balance equations
can be constructed from stoichiometric coefficients of enzymatic reactions
which describe the time differential changes in concentrations as a function
of reaction rates. The balance equations can then be parameterized by mea-
surements of clearance of extracellular substrates and increases in product
concentrations in order to calculate the intracellular fluxes. Figure 1.1 shows
a small metabolic network which can be described in terms of the metabolite
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Figure 1.1: Metabolite balancing. See text.
balance equations in equation set 1.1

X1
′(t)
X2
′(t)
A′(t)
B′(t)

 =


−1.v1 0 0 0
0 0 0 1.v4
1.v1 −1.v2 1.v3 0
0 1.v2 −1.v3 −1.v4

 =


X1
′(t)
X2
′(t)
0
0

 (1.1)


X1
′(t)
X2
′(t)
A′(t)
B′(t)

 =


−1.v1 0 0
0 0 1.v4
1.v1 −1.v23 0
0 1.v23 −1.v4

 =


X1
′(t)
X2
′(t)
0
0

 (1.2)


X1
′(t)
X2
′(t)
A′(t)
B′(t)

 =


−1 0 0 0
0 1 0 0
1 0 −1 1
0 −1 1 −1

 .


v1
v4
v2
v3

 =


X1
′(t)
X2
′(t)
0
0

 (1.3)
If the intracellular metabolites A and B are assumed to be at a steady state,
their time differentials would equal zero. The occurrence of a single entry
in the top left corner of equation set 1.1 indicates that if one would measure
the time differential of extracellular metabolite X1, reaction v1 could be
uniquely determined, and so could v4 be uniquely determined if X2 was
measured. The time differential of an external metabolite can be measured
in a chemostat bioreactor as the concentration of the metabolite multiplied
by a flow constant which is always known, or calculated from the clearance
or production rate in case of a batch fermentation. The latter case would
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be referred to as a quasi steady state. However, the network structure
implicates that v2 and v3 cannot be calculated either by measurements of
any of X1 or X2, or by measuring both. This is because in both rows of A’(t)
and B’(t), the same two reaction variables v2 and v3 occur, which is referred
to as rank deficiency. There are thus too many variables to calculate from
metabolite balances. We can combine columns 2 and 3 into a single column
which describes the net action of reactions v2 and v3 as v2-v3 (equation
set 1.2). From the known v1 we can thus calculate v23 which is the only
other variable in the row for A’(t) and from that we can calculate v4 in
B’(t). This means that we did not actually have to measure B’(t) as the
metabolite balance constraints allowed v4 to be calculated from A’(t).
For this type of calculation, formal mathematical procedures have been de-
fined. The stoichiometric matrix N is separated into two parts. In the first
part Nb, all the fluxes are directly known from measured consumption and
production fluxes. In the second part Nn, all the fluxes have to be calcu-
lated from the network constraints together with the measured part. The
corresponding reaction vectors are rb and rn (see [4] and equation set 1.3).
The stoichiometric matrix equation
0 = N.r (1.4)
thus becomes
0 = Nb.rb +Nn.rn (1.5)
which can be rewritten as
rn = −N
−1
n .Nb.rb (1.6)
N−1n is the precise inverse of Nn, but is actually not used very frequently, for
it is only valid if Nn is square. Therefore, the relation
rn = −N
#
n .Nb.rb (1.7)
is used instead, where N#n is the Moore-Penrose pseudo inverse and is valid
for any matrix [4, 5]. It allows the calculation of rn by a least-squares solu-
tion.
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Some network structures unfortunately make the internal fluxes in metabolic
systems impossible to calculate from the measured external fluxes, as shown
in the example above. Mathematical algorithms have been designed to make
the best use of the available data and calculate as many calculable fluxes as
possible [4, 6–11]. In the example above, measurements of both A’(t) and
B’(t), which will inevitably differ due to measurement errors, can thus be
used maximally because they are balanceable.
However, metabolite balance constraints are generally insufficient for calcu-
lation of realistic metabolic networks. A more powerful approach is to use
substrates labelled with stable isotopes such as 13C, and then to analyse
the isotope labelling patterns of metabolites. By using various statistical
or algebraic methods, the labelling patterns can then be used to provide
the necessary extra constraints to calculate the internal flux distributions.
Theoretical frameworks and experiments for 13C-Metabolic Flux Analysis
(13C-MFA) have recently been improved to become powerful techniques for
flux calculation [3, 12, 13], which is the topic of the next chapter. It is im-
portant that we extend metabolic flux experiments to the omics level to
form the functional complement of the existing data technologies that have
been developed to that scale. A major goal is to be able to use the recent
genome-scale metabolic reconstructions [14] as the basis for flux calculations.
1.2 Flux balance analysis: from observatory flux
calculation to predictive network analysis
Although it is very useful to know the flux pattern in a cell, it is still only
a snapshot of cellular function that is obtained. The use of stoichiometric
models for flux measurements thus has fundamental limits for making pre-
dictions about behaviour in different environments or genetic modifications.
Also, as experimental methods do not yet allow us to calculate fluxes at a
genome-scale, there is a strong emphasis on predictions by the genome-scale
stoichiometric model, as opposed to its use as a measurement model. Flux
balance analysis (FBA) aims to exploit our knowledge of network structure
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at the genome-scale to predict cellular behaviour at a steady state.
A stoichiometric model can be used to predict the range of possible flux
patterns that are allowable to operate in steady state, but does not predict
which of the infinitely many possibilities will be used. It is thus not very
constringent in its predictions. Accordingly, extra hypotheses are used in
combination with the steady state formalism to make more constringent pre-
dictions possible. In this constraint-based modelling approach, [14, 15], the
hypothesis usually used is that metabolic networks are globally optimized for
sustaining maximal growth rates. The experimentally determined biomass
composition is thus included and an optimization routine is applied that
maximizes biomass fluxes from the precursors in the determined ratios. The
system is also constrained at enzyme maximal activities such as substrate
transporters to set the limits for the optimization. The flux capability is
frequently investigated in the dimensions of substrate uptake to study limi-
tation properties of the network in phenotype phase plane analysis [16,17],
or by defining limit potentials [18].
A question is whether these optimization criteria are valid, and whether
they exist at all in nature. Certainly, not all cell types are optimized for
maximizing growth rate, for then some pathways would not be used by
organisms that also have more effective methods of energy production. In-
ference and testing of optimality criteria on actual data is at the heart of
constraint-based modelling. Significant effort is being invested in the iden-
tification of optimality criteria and programs have been designed for this
purpose and can apply more than one criterion [19]. An important step was
the introduction of the idea that mutants usually respond to a gene dele-
tion by striving to return to the wild-type phenotype as well as it possibly
can. The MOMA approach (minimization of metabolic adjustment) [20]
can be used to predict the viability of mutants. MOMA has lately been
applied using phenotypic data in the form of 30 quantified metabolic fluxes
from 13C-MFA experiments from four different wild-type conditions. This
data served as realistic optimization criteria for the large-scale stoichiomet-
ric model iLL672 [21]. Gene knockout strategies for lactate overproduction
in Escherichia coli based on two optimality criteria using OptKnock [22]
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have resulted in lactate overproduction of 25-73%, proving the reliability of
constraint-based FBA predictions.
FBA can also be readily extended to incorporate diverse data types and
constraints. The laws of thermodynamics are applied to the analysis of
metabolomics datasets in Energy Balance Analysis (EBA) [23–25]. FBA has
also been extended to predict dynamic flux responses and genetic regulation
[26–28] and the optimality criteria have been improved accordingly to more
complex formulations [29]. Although it is not yet possible to quantify all
the metabolites in the cell accurately due to difficulties with metabolomics,
large-scale stoichiometric techniques thus provide a way to make use of some
of this data [15]. FBA is thus becoming an efficient framework for capturing
data at the genome scale to complement the omics.
1.3 Genome-scale biochemical network models
A range of genome-scale metabolic pathway representations have been con-
structed during the past few years [14]. Of note are the models of Haemophi-
lus influenzae [30], Escherichia coli [31], Saccharomyces cerevisiae [32, 33]
and for the important human pathogen Mycobacterium tuberculosis [17, 34]
constructed by the groups of Palsson and others. The procedure of re-
construction starts with an annotated genome [32]. Additionally, online
databases, textbooks and literature are also used. This research is a critical
link to the complete genome as reference and forms a broad picture of the
metabolic reactions in cells. The yeast metabolic pathway model iND750
for instance, consists of 1147 reactions and 1061 metabolic species and is
fully compartmentalized into organelles [33].
Like metabolic networks, reconstructions of genome-scale protein interac-
tion networks are also being made but are more difficult to assemble than
metabolic networks [35]. The principles used are more experimentally ori-
entated. The yeast-two-hybrid experimental method to infer protein inter-
actions [36] can provide essential large-scale information, but is difficult to
interpret for there are many false positives. Direct co-purification or in-
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direct affinity tag purification can also be used efficiently to decipher the
localization of proteins into organelles and complexes [35]. Much emphasis
has recently been placed on integration of diverse types of genomic data to
predict protein interaction networks by combining bioinformatics and ex-
perimental approaches [37]. Protein interaction networks can be incredibly
large and interconnected, like the recently reconstructed human interactome
map with more than 7500 mapped interactions [38]. Apart from helping to
elucidate the functions of many uncharacterized proteins, interactomes are
seen as a suitable framework for cellular modelling [39] as they form func-
tional networks.
Signalling networks are also of high importance for genome-scale reconstruc-
tion [40], but are very difficult to construct. Interesting is that signalling
models can be analyzed in terms of many of the same principles used for
metabolism, such as elementary modes [41], and a method has been devel-
oped by which stoichiometric models and signalling models can be analyzed
in a combined way [42,43].
FBA, like other approaches that are based on constraints of network struc-
tures, is limited by the fact that the nonlinear nature of mechanisms - the
enzyme mechanisms, protein interactions and signal transduction - is not
fully captured in a rigid network model. These methods thus have fun-
damental limits in predicting the more complicated emerging properties of
biochemical networks that can only be predicted by taking the concentra-
tions of the biochemical species into account. FBA, for instance, may be
used efficiently for studying the possible effects of gross manipulations such
as the knockouts of enzymes, but the knowledge of more subtle changes in
the biochemical macromolecules that affect their functioning cannot be used
in a sensible manner. On the contrary, deep theoretical analyses of biologi-
cal systems have been done for decades, but without the availability of large
omics datasets, genome-scale reconstructions and bioinformatics. Advanced
mathematical methods in kinetic modelling have been formulated for anal-
ysis of biochemical systems. It now makes sense that these methods should
be applied in combination with bioinformatics and the omics technologies.
The omics and bioinformatics can help us to create and validate kinetic
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Figure 1.2: The structure of a simple kinetic model incorporating non-
stoichiometric effectors. See text.
models, while the kinetic models can help us to make sense of the omics
datasets and guide further experimentation.
1.4 Kinetic modelling and Metabolic Control
Analysis
For kinetic models of metabolism, a stoichiometric model also forms the
network structure as in FBA, but the reaction rates respond to the concen-
trations of modelled metabolites and a steady state is thus not assumed.
Simulation is usually based on a numerical integration of ordinary differ-
ential equations, and sometimes partial differential equations. The method
could thus be used to study a biochemical system functioning at the steady
state [44,45] or to study non-steady state behaviour such as the oscillatory
behaviour found in metabolism [46,47] and in the cell cycle [48–50].
For a good introduction to the formulation of a kinetic model, see [51]. The
metabolic network in figure 1.2 with feedback and feedforward loops can be
described in terms of the stoichiometric matrix equation

X1
′(t)
X2
′(t)
A′(t)
B′(t)

 =


−1 0 0 0
0 0 0 1
1 −1 1 0
0 1 −1 −1

 .


v1
v2
v3
v4

 (1.8)
where each of the reactions in the reaction vector is now a rate equation
which describes the reaction rate as a function of the metabolite concentra-
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tions (M), and various enzyme kinetic parameters (P).


v1
v2
v3
v4

 =


v1
(
M
[
X1, A,B
]
, P
[
Vmax1,Keq1, P1X1, P1A, P1B
])
v2
(
M
[
A,B
]
, P
[
Vmax2,Keq2, P2A, P2B
])
v3
(
M
[
A,B
]
, P
[
Vmax3,Keq3, P3A, P3B
])
v4
(
M
[
A,B,X2
]
, P
[
Vmax4,Keq4, P4X1, P4A, P4B
])


(1.9)
One could make distinctions between the different types of kinetic models
based on the way they are constructed. Of note, it is important to dis-
tinguish between models constructed from rate equations and parameters
obtained in vitro, and models of which the parameters are fitted to concen-
tration time series data. Teusink et. al. characterized the individual en-
zymes in vitro for their kinetic parameters and constructed a detailed model
of yeast glycolysis [44]. Rate equations in this model reflect the real cellular
machinery, for example the reversible Michaelis-Menten rate equation used
for the hexose isomerase
v = Vmaxf
[S]
Ks
−
[P ]
KsKeq
1 + [S]
Ks
+ [P ]
Kp
(1.10)
Some mechanistic rate equations are very complex, for example the Monod-
Wymann-Changeux equation which can describe the phosphofructokinase
with its many metabolic effectors and binding cooperativity (see Appendix
A). Many other detailed equations have been derived which reflect the differ-
ent mechanisms by which enzymes catalyze their reactions and the order in
which the implicit enzymatic steps are catalyzed. By contrast, Rizzi et. al.
fitted kinetic parameters to a set of semi-realistic enzyme kinetic equations
during an in vivo substrate pulse experiment [52]. In the first example,
a model was constructed from the reductionistic knowledge of the parts
(enzymes), whereas in the second example, time-dependent data was used
to infer parameters. An important concept for us is context dependence.
The realistic in silico enzymes in the Teusink model could function under
many conditions (contexts), for it can readily be claimed that the equations
describe real enzyme properties. On the other hand, a model with fitted pa-
rameters might not be used realistically in conditions that are much different
Chapter 1. Systems Biology, Omics, and the Silicon Cell 11
from those used for model construction. Context-independence arises with
increasing accurately modelled detail that describes the mechanism of the
process. It is important to note that if the same detailed equations could be
used for fitting, the same level of context-independence could be achieved.
However, during fitting, an integrated system of equations with many pa-
rameters and variables has to be fitted. Although separation of a model
into smaller dynamic subsystems [52] provides a more direct link between
dynamic data and enzyme parameters, the current accuracy and scope of
metabolomics data does not allow such detailed equations to be used with
good confidence [15]. However, quantitative metabolomics technology will
improve in the future and enable fitting of detailed model parameters which
will approach the detail obtainable with the in vitro approach. In any case,
it is our objective to use such dynamic experiments mainly for validation
purposes, with model construction based on characterization in vitro.
Whatever the method of model construction and validation, advanced math-
ematical frameworks have been developed for making predictions from a
model, of which the most notable is Metabolic Control Analysis (MCA) [53].
Since its initial formulation [54] it has been extended several times to result
in a very powerful analytical framework [55–59]. MCA provides metabolic
control coefficients and metabolic response coefficients. In its original for-
mulation, a flux control coefficient CJv can be defined as the response of any
steady state flux J to an infinitely small change in a reaction rate v, and
a concentration control coefficient CSv as the response of any steady state
concentration S towards a small change in a reaction rate v. Flux response
coefficients RJp and concentration response coefficients R
S
p are those sensi-
tivities towards small changes in any of the parameters in the model. Apart
from the conventional steady state analysis of biochemical systems, MCA
has also been developed for oscillating biochemical systems [60]. The most
recent development is a generic approach based on perturbations to char-
acterize many other time-dependent aspects that cannot be addressed with
other approaches [61]. MCA is thus a powerful method for determining the
response of a biochemical system towards perturbations.
How informative the deductions from MCA may be [62], the main factor
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that has been hampering the large-scale use of MCA, and kinetic modelling
in general, is the uncertainty of how realistic such models are. The effects
of molecular crowding, metabolite channelling and spatial effects in the cell
are concerns. An important recent development in MCA has been the in-
troduction of a framework to incorporate the uncertainties associated with
kinetic parameters, metabolite concentrations and metabolic flux measure-
ments [63]. Monte Carlo Simulation has been used to model the uncertain-
ties, which are then projected via the (log)linear MCA formulation to the
control coefficients. Incorporation of probability theory is an exciting new
development that allows us to interpret model predictions for what they are.
It is interesting to note that also in 13C-MFA [64] and FBA [65] there is great
interest in Monte Carlo Simulation for its ability to handle uncertainties as
well as large systems.
1.5 Omics meets systems biology and
bioinformatics
Many of the kinetic modelling endeavours in the past have aimed to explore
possible biological behaviours by varying parameters and equations. How-
ever, in the post-genomic era it is of crucial importance to also model what
actually happens [66]. The large datasets obtained from omics present com-
plex profiles and systems biology is needed to understand it better. Such
models must accordingly be made at a scope and level of detail that is simi-
lar to that of the omics datasets. Both constraint-based FBA and the more
complex kinetic modelling will have to be streamlined towards such a regime.
Constraint-based modelling is already at the level of the omics in terms of
scale, but lacks in detailed predictions. Kinetic modelling with MCA is very
detailed and can now incorporate uncertainties in parameters, but lacks in
scale and thus practicality. The detailed understanding of biochemical sys-
tems that large-scale kinetic modelling can provide is attractive, therefore
our long-term goal is the creation of an in silico replica of a cell, represented
by the Silicon Cell Initiative [66]. Metabolism is our starting point, but
the genome-scale description will eventually take all levels of regulation into
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account. We want to test the Silicon Cell under many different conditions
and manipulations, therefore the rate equations must have context indepen-
dence [66], the same way that an organism uses the same cellular machinery
at different expression levels under many different conditions. From this
viewpoint it thus makes sense that detailed enzyme kinetics (in the case of
metabolic reactions) is preferable to phenomenological rate equations which
do not represent any cellular mechanism.
The need for parts-based information also implies a number of other con-
siderations. It is true that in this way the information of the parts collected
during the past century can be used in an appropriate manner. However,
more important is to consider that the face of biological science is chang-
ing rapidly. The recent past has shown us how biological information has
been made accessible in a structured way in the form of genomic databases.
Information became linked to individual genes in genomics databases as in-
formation hubs. The scientific community realized that the concept of a
gene is not as constant as initially thought, and that the gene might be
far from the level of functional phenotype, as a result of the hierarchical
levels of regulation. Functional genomics has accordingly shifted its frame
of reference somewhat towards proteins, where protein databases are now
the format for linking biological information. In terms of building a parts-
based Silicon Cell, this is very convenient for us. It is remarkable to note
how the UniProt database has arisen as the authorative resource for pro-
tein information [67–70]. Via UniProt, many diverse types of information
from many resources are made accessible and structured around individual
proteins. UniProt is continuously updated and more types of information
are made available, while the process is curated by a large team of biolo-
gists. The diversity of biological databases has for long made multifaceted
studies very complicated. Accordingly, a project that needed diverse data
types from many resources had to be both very computer informatics in-
tensive and required scientific knowledge of various fields, and thus only a
large team could execute a multifaceted project successfully. The aim of
the UniProt Consortium is to enable the individual researcher the luxury
of diverse data types, structured around proteins. It is likely that all of
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the most important protein-related information in databases will soon be
available through UniProt. Such an initiative means that one does not need
to be a bioinformatics expert to acquire diverse parts-based knowledge.
One of the recent additions to UniProt is enzyme kinetic information, which
could be used directly in kinetic modelling, as is also found in the Brenda
[71], CCDB [72] and SABIO-RK databases [73]. Other diverse annotations
in UniProt include, for instance, associations with diseases. At first glance,
the latter type of information may not be very useful from a kinetic mod-
elling perspective, for it is not a recognizable parameter in kinetic models.
Neither could diseases be completely described in terms of the function of
a single protein. However, working with such information is important to
keep a strong link with reality so that we can address real-world problems.
We should thus make it an aim in the Silicon Cell Initiative to implement
elements from bioinformatics that will help us to make systems biology prac-
tical and address real-world problems. The first genome-scale Silicon Cell
should thus not only be a model to understand how the organism Saccha-
romyces cerevisiae or Escherichia coli works. It has to result in a generic
framework for interpreting omics datasets and parts-based knowledge, which
will help us to address a multitude of biological problems.
1.6 Steps towards building the Silicon Cell
For the Silicon Cell Initiative, a modular approach has been suggested [66,
74]. In this approach, the total cellular description can ultimately be created
from a number of modules which are small kinetic models built by individ-
ual researchers or research teams, specializing in those parts of the cellular
puzzle. Kinetic modules that have been built so far are stored in the JWS
Online model database (http://jjj.biochem.sun.ac.za) which is a repository
for parts of a Silicon Cell. General outlines for building context-independent
kinetic modules have been given elsewhere [66].
Kinetic modules should be non-overlapping entities in a global cellular net-
work which have a well-defined connectivity structure. One would therefore
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think that we first need a roadmap in the form of a metabolic pathway
network, the likes of which have been created recently for a number of or-
ganisms, including yeast [33]. We could thus build a network of connected
kinetic modules on top of these representations to guide the process. This
reference network should then also be our link to the information in gene,
protein and metabolite databases, forming the information link between sys-
tems biology and the principles of bioinformatics.
Different from a top-down approach that would aim to first make less-
detailed descriptions of the cell and then replace parts with detailed de-
scriptions of cellular machinery [1], our approach is to start with detailed
parts-based descriptions and work towards combining them. This implies
that we have to obtain detailed data of a large scope of metabolism that
will function: 1) as validation data for the kinetic parts, and 2) as boundary
constraints for correct simulation of kinetic parts. Figure 1.3 illustrates this
flux-constrained approach.
We focus here on metabolic flux data at the steady state, where steady state
metabolomics and dynamic pulse experiments can follow in the future. The
need for detailed flux data implies that we use stable isotope based meth-
ods, as will be explained in Chapter 2. The use of a flux model, which is
inevitably a simplification of the genome-scale representation, implies that
the kinetic modules are not built directly on the genome-scale network, but
are linked via the abstraction of the flux model (see figure 1.4). As metabolic
flux technology improves (which will be enabled by advances in metabolo-
mics), the flux models will increasingly become similar to the genome-scale
stoichiometric model, but flux data is always linked via the abstraction of the
quantifiable flux model. We thus have to assume that the reactions which do
not feature in the flux model proceed so slowly that they can be ignored in
flux calculation. Chapter 3 is a theoretical treatment of the linkage between
a kinetic module and metabolic flux data.
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Figure 1.3: Combining a flux data model with a kinetic model. Grey arrows
are measured fluxes in the flux model. Black arrows are reactions in a kinetic
model. Data values are replaced with kinetics. The boundary reactions have
to be incorporated correctly.
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Figure 1.4: Kinetic modules are connected to the genome-scale pathway
maps through data models. In this case it is a 13C-MFA model of central
carbon metabolism which serves as boundary constraints and as basis for
accuracy assessment.
Chapter 2
Theoretical aspects of
13C-metabolic flux analysis
Excellent reviews on the history, experiments, mathematics and statistics
behind 13C-MFA are given by Fernie et al. [3], Wiechert [12] and Sauer
[13]. Specific mathematical concepts are described in detail in [64, 75–90],
and the basis for experimental techniques are described, for nuclear mag-
netic resonance spectroscopy (NMR) [85, 91], for GC-MS [87, 92] and for
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF-MS) [93, 94]. Only the basic principles are explained in the
next two sections.
2.1 Analysis of data from isotope labelling
experiments
In 13C-MFA, cells are provided with substrates that are labelled (13C as
opposed to the unlabelled, 12C form) at certain positions and in certain per-
centages. The isotopic tracer atoms are then distributed in the metabolic
system and by analyzing the labelling patterns of metabolic intermediates,
the reaction rates through various metabolic pathways can be calculated.
What determines whether a certain metabolic flux, or rather a ratio between
fluxes can be calculated, is the specific labelling pattern of the substrate,
18
Chapter 2. Theoretical aspects of 13C-metabolic flux analysis 19
and the atom transitions in the metabolic network. Figure 2.1 gives an indi-
cation of the ways that isotope labelling information is distributed through
a metabolic network.
In A, pathways J1 and J2 can be distinguished by supplying a substrate
labelled in the second position (indicated by a black dot). The labelled
atom is cleaved off in pathway J2, therefore it will not be present in the
product. Pathway J1 cleaves off the atom in the first position, therefore
its activity leads to the labelled end product. The ratio between the two
pathways can thus easily be calculated as the ratio between the two isotopic
forms of the end product.
In B, pathways J3 and J4 do not cleave off any of the atoms, but the atoms
are rearranged only in J3. The result is that the pathways produce the
same number of labelled atoms as unlabelled atoms in the end product
(they produce equal fractional labelling). However, the labelling patterns
are different. The different types of labelling patterns in a molecule are re-
ferred to as isotope isomers or isotopomers, for they are the same chemical
structures, but differ only by their isotopic pattern. The flux ratio between
the two pathways could thus be calculated as the ratio of these two iso-
topomer fractions. Note that the concentrations of these metabolites are
not important, only the isotopomer fractions. Note also that for this path-
way structure, we do not need to measure the isotopomer fractions in the
two intermediate metabolites, for we know from the atom transitions what
their isotopomer fractions will look like (if our knowledge of the pathways
and carbon transitions is correct).
In C, pathways J5 and J6 neither cleave off atoms nor catalyze different
carbon transitions. They result in exactly the same isotopomer fractions in
the end product, which presents a problem. The only way how such a ratio
could be calculated is if we would carry out an experiment in which the la-
belling pattern changes over time, in order to calculate a turnover rate. We
would thus have to measure labelling patterns in the intermediate metabo-
lites during a time-series in which the concentrations of the metabolites are
constant (metabolic steady state) but the isotopomer fractions change over
Chapter 2. Theoretical aspects of 13C-metabolic flux analysis 20
J8J7
J2J1
J6J5
J4J3
J10J9
A
C
B
D
E
X Y
X Y
Z
U
V
Figure 2.1: Various ways in which labelling information is generated through
metabolic systems. Boxes indicate pools of a metabolite with various pat-
terns of labelling. A. Pathways split molecules in alternative ways. B. Path-
ways use alternative rearrangements of atoms in molecules. C. No splitting
of molecules or rearrangement of atoms. D. No splitting of molecules or re-
arrangement of atoms occurs, but one pathway catalyzes sequential splitting
of a molecule and condensation of products. E. The scrambling effect in a
condensation reaction generates information of its activity to the condensa-
tion product in a probabilistic manner.
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time. Such an isotopic transient can be induced by growing the organism
on the natural (12C) substrate in a chemostat, and waiting for a metabolic
steady state. The substrate inflow is then switched to the labelled (13C)
substrate, and the labelling patterns in the intermediate metabolites will
show a labelling transient. If the concentration of a metabolite is known,
as well as its labelling transient dynamics, the flux through such a pathway
could be directly calculated [3, 84].
In D, pathways J7 and J8 also do not result in distinct carbon transitions
which present the same problem as in C. However, this case is different
due to the fact that pathway J8 splits the substrate and combines it again.
At first glance, this is not an important fact, for the end product has the
same labelling patterns via both pathways. However, the second part of J8
catalyzes a condensation reaction, preceded by a randomized scrambling of
all the molecules in each of the pools X and Y. In this example, all substrate
molecules are 100% 12C in the first position and 100% 13C in the second
position, therfore all X are 12C and all Y are 13C. Chances are thus 100%
that an unlabelled X and a labelled Y will combine to form 100% of 12C-13C
Z molecules.
However, if the substrate would be a combination of fully unlabelled and
fully labelled molecules as in E, then X and Y would each contain both 12C
and 13Cmolecules. When they are combined again in the bottom part of J10,
combination by chance will result in isotopomer fractions of Z corresponding
to 12C-12C, 13C-12C, 12C-13C and 13C-13C patterns. This is opposed to the
12C-12C and 13C-13C isotopomer fractions that are produced by pathway
J9 that does not split and recombine the molecules. Such information can
be handled conveniently in terms of isotopomer distribution vectors (IDV’s)
and probability theory. An IDV is the vector of isotopomer fractions of a
metabolite pool. The elements can have values between 0 and 1 and they
add up to 1. The number of isotopomer fractions n in an IDV can be
calculated from the number of atoms a as
n = 2a (2.1)
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In a condensation reaction with two substrates and a product, there is a
probabilistic relationship between the isotopomer fractions of the substrates
and the product given by
IDVZ = IDVX ⊗ IDVY (2.2)
where IDV is the isotopomer distribution vector of the product (IDVZ) and
substrates (IDVX , IDVY ) and (⊗) is an elementwise multiplication. IDVZ
thus has the number of
nZ = nX × nY (2.3)
elements. In this way, the IDV of any condensation product can be calcu-
lated from measured or calculated IDV’s. Similarly, if the IDV’s of products
are known, the IDV’s of their substrates can be calculated by least-squares
fitting. These two calculations, along with techniques for correcting for nat-
ural abundances of isotopes [86, 90] are the basis for the derivation of the
labelling patterns of metabolites via other metabolites. For example, in the
retrobiosynthetic or biosynthetic fractional labelling (BFL) approach [85],
the labelling patterns of metabolic intermediates are derived via labelling
patterns in the amino acids, which are synthesized from these precursors
and are much more abundant and stable.
In a direct probabilistic approach to 13C-MFA, flux ratios can be calculated
based on measured or derived isotopomer fractions. A very effective method
is Flux Ratio Analysis or METAFoR analysis [85, 86, 88]. For scheme E,
the IDV of the product IDVZ could be synthesized firstly through pathway
J9 from pathway intermediate V. From the atom transitions it is known
that IDVV will have the same labelling pattern as the growth substrate
with known IDVU . Alternatively, the product could be synthesized through
pathway J10. We can calculate the labelling pattern in its condensation
product (call it IDVXY ) from the split and recombined substrate IDVU . X
and Y are fragments of the substrate U isotopomers, therefore IDVX and
IDVY can easily be determined. IDVX and IDVY can then be used to obtain
IDVXY by equation 2.2. The contributions of the two pathways can thus
be calculated as follows: IDVZ is produced from IDVU and IDVXY via the
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relationship
IDVZ = f × IDVXY + (1− f)× IDVU (2.4)
where f is the ratio of J10/(J10+J9), which can be rearranged to yield
f =
IDVZ − IDVU
IDVXY − IDVU
(2.5)
In practice, the methods by which isotopomers are observed, sometimes do
not allow the full isotopomer distributions to be calculated, but derivations
from it. For instance, MS allows assignment of mass distribution vectors
(MDV’s). In an MDV, all the isotopomer fractions with the same number of
labelled atoms are grouped in the same element, as they are observed in the
same signal in MS (see figure 2.2). For a molecule with n atoms, there exists
n+1 mass isotopomers in the MDV. There is thus a reduction in information
potential from 2n isotopomers to n+1 mass isotopomers. Fortunately, we
can regain some of the hidden information by using fragmentation methods
in MS. For each fragment an MDV can thus be assigned which provides
further constraints. For mass spectrometry data, the IDV’s in all of the
equations above are thus replaced by the MDV’s as explained in [86]. An
MDV can be assigned for each metabolite fragment in an MS and ratios are
thus based on MDV’s of fragments using equation 2.5.
Mass isotopomer signals can be seen for two metabolites in a GC-MS, op-
erated in electron impact ionization mode in figure 2.3. In figure 2.4, the
fragmentation patterns of the same metabolites become visible, where each
fragment cluster consists of different mass isotopomer signals. Figure 2.5
gives a global view of the elution pattern during the first few minutes of
elution showing the complex fragmentation patterns.
For each ratio calculated, a standard deviation can be assigned. This is
based on an estimation of experimental error of the mass spectra, by com-
paring the amino acid MDV’s with identical carbon skeletons. This error is
used for calculating the standard deviation of the ratio by the law of error
propagation. For a discussion of error estimation of ratios, see [86].
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Figure 2.2: The labelling pattern of a metabolite pool can be described in
terms of isotopomer fractions. Mass spectrometry data provides information
of mass isotopomers, which are combinations of isotopomers that have the
same mass. Positional labelling is the fraction of all atoms at a certain
position in a molecule that are labelled.
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Figure 2.3: 2-Dimensional view of mass isotopomer signals in a GC-MS
with a quadrupole mass spectrometer operated in electron impact ioniza-
tion mode. The different lines in one peak (metabolite) are different mass
isotopomer ions that elute from the GC over time. The two metabolites
are alanine (left) and glycine (right). Data of hydrolyzed 13C glucose grown
yeast biomass was obtained in this study. Details of the GC-MS procedures
are given in section 5.1.5.
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Figure 2.4: 3-Dimensional view of mass isotopomer signals in GC-MS of the
hydrolyzed 13C glucose grown yeast biomass. Fragments of alanine (left)
and glycine (right) become visible as ion clusters, each consisting of different
mass isotopomers.
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Figure 2.5: Mass isotopomer signals in GC-MS during the first few min-
utes of elution of the hydrolyzed 13C glucose grown yeast biomass. Many
fragment ions are seen for each metabolite.
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Flux ratio f
f =
J10
J10 + J9
(2.6)
is a constraint between fluxes at the steady state, and can be incorporated
together with the stoichiometry based metabolite balance constraints of flux
analysis. This equation can be rewritten as
0 = (1− f)J10− (f)J9 (2.7)
The latter equation has the same form as the rows of metabolite balances in
stoichiometric flux analysis. However, for some ratios, only upper and lower
limits can be assigned arising from the fact that labelling information of
some metabolites is not available, and assumptions have to be made. Such
ratio limits are of the forms
l ≤
Ja
Ja + Jb
(2.8)
and
u ≥
Ja
Ja + Jb
(2.9)
where l is a lower limit and u is an upper limit. These inequalities cannot be
used in the conventional matrix based calculations of metabolite balancing,
and numerical search routines have to be used. In 13C-constrained flux
balancing [87], the equality constraint
0 = (1− f)J10− (f)J9 (2.10)
is implemented in the search routine as
R = (1− f)J10− (f)J9 (2.11)
together with metabolite balances, measured extracellar fluxes and inequal-
ity constraints. R is the residual of the constraint. The routine seeks to
minimize the sum of the squared residuals, each divided by a measurement
error. These measurement errors are in the form of variances (squared stan-
dard deviations) from the ratios and the extracellular metabolite production
and consumption rates. For a detailed explanation of the routine and the
statistical methods, see [87]. In cases where the reaction structure around
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Figure 2.6: An isotopomer labelling system. For each isotopomer in the
system a mass balance equation is written that describes its production
rates minus its consumption rates.
a certain metabolite is very certain, the user specifies that the metabolite
should be balanced. The algorithm incorporates its residual value R and
seeks to minimize the scaled, squared sum of R values. Most of the metabo-
lites will be balanced in this manner. The smaller these residuals at the
end of minimization, the more certain we can be about the network model
used. However, the reaction structures around cofactors such as NADH,
NADPH and ATP are less certain than most other metabolites, and it
is thus attempted to leave their residuals as variables, representing their
net production or consumption fluxes. The algorithm does not incorporate
these balances in the minimization. In our study, the FiatFlux software
program [95] was used which is based on METAFoR analysis with GC-MS
data and 13C-constrained flux balancing for net fluxes.
Another approach to calculation of metabolic fluxes is to create an iso-
topomer labelling system (ILS), which is a model of all the isotopomers in
a metabolic system. In this approach, each isotopomer is balanced by its
production and consumption fluxes. A detailed explanation of ILS’s has
been given in [79] and [80]. For the case of our example in figure 2.6, the
mass balance equations for the isotopomers of only metabolite E, in an ILS
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will look as follows:
d e00
dt
E = (b00)J1 + (c0. d0)J2− (e00)J3 (2.12)
d e10
dt
E = (b01)J1 + (c0. d1)J2− (e10)J3 (2.13)
d e01
dt
E = (b10)J1 + (c1. d0)J2− (e01)J3 (2.14)
d e11
dt
E = (b11)J1 + (c1. d1)J2− (e11)J3 (2.15)
The upper case name indicates the metabolite concentration of E and the
lowercase of the same name with the binary digit subscripts indicates its iso-
topomer fractions. The digits represent the carbon atoms in the molecule.
A 1 in the subscript indicates a 13C and a 0 indicates a 12C. For metabolic
and isotopic steady state, the fractions of the isotopomers e00, e10, e01, e11
will not change over time. The balances for all the isotopomers of E are
thus equal to zero. The assumption of isotopic steady state thus makes the
concentration of E irrelevant. Further, because isotopomer fractions (and
mass isotopomers) sum up to 1, the number of constraints (equations) is
reduced by 1, for the last fraction can always be calculated from the other
fractions. It can be seen that the probabilities of formation of isotopomer
fractions in E is modelled as multiplication terms of the relevant fractions of c
and d. These multiplication terms give ILS’s their nonlinear characteristics,
as opposed to the linear constraints of metabolite balances. Atom transi-
tions, or rather isotopomer transitions are mapped between molecules with
isotopomer mapping matrices or isotopomer transition matrices (see [79]).
By now it is also evident that the number of atoms considered drastically
increases the number of possible isotopomers of a molecule. There are 2n iso-
topomers for each molecule with n atoms which means that for a molecule of
10 carbon atoms to consider, 1024 balance equations have to be included in
the model. Flux calculation with ILS’s thus presents a strong need for super
computing as the simulation procedure is computationally expensive, and is
especially dependent on computer memory. A bigger problem is that large
simultaneous forward and reverse fluxes (exchange fluxes) cause convergence
problems with most of the algorithms designed thus far. The solution came
with the introduction of cumomer labelling systems (CLS’s) and conversion
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of cumomer fractions to isotopomer fractions. A cumomer fraction is the
fraction of a part of a metabolite that is labelled in a specific way. That
is, regardless of the labelling of the rest of the metabolite (see [79] for an
explanation of cumomers). This treatment allows matrix-based solution of
isotopomer fractions as a function of flux inputs. The numerical search rou-
tine seeks to minimize the discrepancy between the simulated isotopomer
fractions and measured isotopomer fractions. The flux inputs that yield
closest isotopomer fraction comparisons are then taken as the best values.
Apart from the representation as isotopomers, there is also the positional
representation, which is actually the more conventional formulation of a
labelling system (see [76–78]). Positional labelling can be explained as the
percentage of all atoms at a specific position in the molecule that are labelled
and values can range from 0 to 1 (see figure 2.2). There are thus n elements in
the positional labelling vector of a metabolite with n atoms and n balance
equations. Accordingly, the size of the labelling system does not expand
exponentially with the number of atoms in each molecule, which makes
positional labelling systems computationally less expensive. However, large
exchange fluxes cause the same conversion problems as with ILS’s.
2.2 Detection of labelling patterns by nuclear
magnetic resonance spectroscopy and mass
spectrometry
The isotopomer distribution is the most detailed form of measurement that
one can make of the labelling state and is more informative than positional
labelling. Isotopomer fractions can be observed by two methods, namely
MS and NMR.
NMR became particularly useful in flux analysis in two-dimensional het-
eronuclear single-quantum coherence [13C, 1H] correlation spectroscopy (2D-
[13C, 1H]-COSY) of amino acids [85,88]. 2D-[13C, 1H]-COSY detects intact
13C-13C-fragments, therefore the experiments are usually conducted with a
single substrate such as glucose which is uniformly 13C-labelled (at all car-
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bon positions) in a certain percentage, usually 10 or 20 percent. The ability
of 2D-[13C, 1H]-COSY to quantify linear combinations of isotopomer frac-
tions, together with its sensitivity and efficient resolution of amino acids,
makes it suitable to study the central carbon metabolism. Although less
sensitive than MS and thus smaller in scope, NMR can give very precise in-
formation of the positions of the heavy isotopes. It does not mean however
that the scope of NMR cannot be increased [3]. A problem with 13C NMR
methods is that it can only detect the 13C isotope and the 12C isotope is not
detected, thus many isotopomer fractions are not accessible. Linear combi-
nations of isotopomers are detected that have the same 13C, 13C-13C and
13C-13C-13C labelling pattern, but not all fractions are detected. Addition-
ally, some 13C isotopomers cannot be resolved because they have the same
resonance. A new approach is to use heteronuclear spin echo difference NMR
spectroscopy. This proton NMR method can be used to indirectly observe
both the 13C and 12C atoms to calculate even full isotopomer distributions
in some cases [91].
MS has become very practical recently and its extraordinary sensitivity, effi-
cient coupling to pre-separation techniques, rapid experimental analysis and
the small amounts of sample necessary, makes it more applicable for high-
throughput data acquisition than NMR. Gas-chromatography coupled to
mass spectrometry (GC-MS) is a very fast and practical method for obtain-
ing labelling patterns in microbes and experiments have been miniaturized
effectively to culture volumes as small as 1.2 mL for subsequent GC-MS
analysis [87,92,96,97]. As was mentioned earlier, the retro-biosynthetic ap-
proach is the standard practice for 13C-MFA, wherein the labelling patterns
of metabolic intermediates are accessed via the labelling patterns of the
monomers of biopolymers, which are synthesized from the intermediates.
For GC-MS, amino acids are freed from their biopolymers by hydrolysis.
In order to make the amino acids sufficiently volatile to evaporate into the
GC column, the hydrolyzed cellular matter containing the amino acids is
treated with a derivatization agent such as N-(tert-butyldimethylsilyl)-N-
methyltrifluoroacetamide (MTBSTFA) and a suitable organic solvent such
as dimethylformamide (DMFA). The derivatized amino acids are separated
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from other cellular components in the GC column and electron impact ion-
ization (EI) is applied that fragments the derivatized compounds. Where
information in MS is limited by the fact that mass isotopomers are observed
and not isotopomers, fragmentation provides information that resembles
isotopomer fractions closer. Here, different derivatization agents may also
produce alternative fragmentation patterns.
MALDI-TOF MS, which is very new to 13C-MFA is a very rapid and sensi-
tive analytical tool for the analysis of external metabolites or amino acids.
Analyses can be carried out without derivatization, but derivatization adds
to the scope of metabolites that are observed. Culture supernatant samples
as small as 1 µL have been used for detection of labelling patterns [93,94].
From a practical perspective, the local and ILS approaches each have advan-
tages and drawbacks. While the directed approach of flux ratio calculation
works very well for calculation of a few fluxes, analysing a new metabolic
system can be intimidating. The modeller needs to know all the theory
behind the method in order to model explicitly the ratios directly from la-
belling data. The ILS approach is more generic and thus more usable for
many different pathway structures. It is also more suited to extention to
different situations, such as dynamic flux responses in which the concentra-
tions, fluxes and labelling patterns change over time. The ILS programs
are readily made to take network structure inputs in the form of reactions.
Atom transitions are specified as strings of letters in both the substrate and
the product, where the letter (atom) is transferred to the substrate at a
certain position in the string. The mapping matrices or transition matrices
are then automatically generated from these.
It must be said in this regard that it is easier to create such a user friendly
interface in the ILS approach because of its generic nature, but it is still
only a feature of the software, and not of the actual analytical method. The
features that make the available ILS programs user friendly could also be
applied in programs for the local approach, in a modified form. This will
have to feature in programs to enable genome-scale analyses.
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Computational complexity also has some practical implications. Large sys-
tems, and especially large molecules can make ILS simulations prohibitively
computationally expensive, whereas the local approach does not suffer from
this problem. In this regard, the group of Wiechert are implementing par-
allization of the flux algorithms [98].
From a fundamental perspective, there are also advantages and drawbacks,
although the two methods will ultimately provide the same answers if used
correctly. ILS simulation is an integrated approach which means that it
is model dependent. If there are mistakes in a network model used, the
complete flux distribution will be calculated wrongly, while the strictly local
flux ratio approach is better suited to validate a network structure. Genome-
scale flux analysis will likely require a combined approach.
Chapter 3
Flux-constrained kinetic
modelling: dealing with
parts of a Silicon Cell
Kinetic modelling, like other forms of systems biology, now needs to embrace
high-information technologies for creating and validating models. A rigorous
methodology for this integration has to be developed in which kinetics can be
quantitatively compared to physiological data to locate dubious parameters.
There is however more to this integration process than a mere comparison
of model predictions with data. For every kinetic model built, a large part
of the cellular network is assumed to be non-existent.
In the first section of this chapter it is explained why it is necessary to include
flux measurements of the rest of metabolism into a kinetic simulation. Only
then can the existing kinetic parts be expected to portray realistic behaviour.
This involves a different treatment of the system boundary conditions.
The new inclusion of boundary reactions involves a number of other im-
plications for accuracy assessment. Establishment of extensive accuracy
assessment is necessary before increasing the size of a kinetic model, and
before predictions can be made from it. It is discussed that the integrated
nature of kinetic models makes it difficult to locate errors, especially with
only partial, or no metabolite concentration data. Section 3.2.1 explains
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how the formulation of kinetic models can be altered for more constringent
accuracy assessment by setting of pathway fluxes to measured values. A
special type of data that we investigate for this integration and accuracy
assessment process is that of 13C-MFA experiments. In section 3.2.2 it is
shown to have interesting properties which can be used as an in vivo method
for partial accuracy assessment.
The flux-constrained methodology introduced in this chapter involves a num-
ber of technicalities to be considered. Setting of pathway fluxes and con-
served moieties hold implications which are discussed in sections 3.3.1 and
3.3.2 respectively.
Steady state data is limited in its information content and thus not very
constringent as a data source for accuracy assessment. Dynamic substrate
pulse experiments have high potential for accuracy assessment because they
link many data points to kinetic parameters. However, these experiments
suffer from a number of problems to be discussed in section 3.4. It is sug-
gested that such experiments should be complemented by a steady state
accuracy assessment protocol using the principles explained in sections 3.1
to 3.3.
Predictive capability, such as MCA, is altered, but in section 3.5 it is ex-
plained how a recent MCA framework may be used to make prediction
possible.
In response to these findings, a simple prototype integration software pro-
gram was written in Mathematica, which is the topic of the next chapter.
This program can now serve as part of a comprehensive protocol for accuracy
assessment and model improvement.
3.1 Boundary conditions in kinetic models
The modular approach for the Silicon Cell, in which many kinetic models
are ultimately combined to form a whole, was discussed in Chapter 1. A
main feature of the modular approach should be the existence of a very
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large reference biochemical network which is extensively characterized with
reaction and concentration data from both steady state and dynamic exper-
iments. The structures of kinetic modules must correspond to parts in the
data model. It is obvious that some measured reactions will correspond to
the reactions in the kinetic model and others will fall outside of the kinetic
model. Those data reactions that have a complement in the kinetic model
will in some way be used for comparison with the simulation outputs of the
kinetic model in the validation process. As biological pathway networks are
in fact integrated systems, each kinetic part must be fully integrated with
the rest of the system, either through other models or through boundary con-
ditions. Due to the fact that we do not have models for the whole system,
boundary conditions are used which have values that have been measured
in vivo. All entities that are not treated as variables during a simulation,
which are expected to have different values at each physiological condition
are boundary conditions. They have to be measured for each such condi-
tion and used as numerical inputs in kinetic models in order to simulate the
system.
The boundary conditions frequently used in detailed enzyme kinetic models
are: 1) metabolite concentration boundaries and 2) maximal activities of
enzymes. Entities which we assume that we can extrapolate to all condi-
tions include enzyme parameters such as saturation, inhibition, activation
and cooperativity constants, which can be measured in vitro. Factors such
as pH and temperature also alter the behaviour of enzymes, but usually
these effects are minimal over the range of conditions that a model is used
for. These effects usually do not feature in the rate equations and are thus
implicit in the other parameters.
3.1.1 Concentration boundaries
Concentration boundaries are the concentrations of metabolites that affect
the modelled pathways and which are not treated as variables in a simula-
tion. These include direct products and substrates of the pathways of inter-
est, for instance, extracellular glucose and glycerol, and are featured in the
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rate equations. They are generally treated as constant over time for steady
state modelling or can equally validly be incorporated as equations that de-
scribe the measured concentrations as a function of time. For instance, if a
system of rate equations is tested against time-dependent data from a dy-
namic substrate pulse experiment, this will be a more valid procedure than
to make the assumption that a boundary metabolite stays constant. Also,
the rate equations can feature concentrations of other effectors influencing
them which are not synthesized or produced by the local system, but are
variables of other parts of the larger system. Typically, these are activators
and inhibitors of the modelled system and do not feature in its stoichiome-
try. They too can be treated as constants for steady state modelling or as
time dependent equations.
The concentration boundaries, which have their data analogue in metabolo-
mics, are thus relatively simple to incorporate: the relevant concentrations
are simply used as constants or time-dependent values in the rate equations.
Although there are difficulties in the technique of metabolomics itself, like
identification of peaks, conversion to concentrations, sampling, derivatiza-
tion, preservation and statistical considerations of combining different data
sets, the final answer is a concentration which should directly relate to an-
other concentration in the kinetic model.
3.1.2 Enzyme boundaries
The second type of boundary conditions referred to here is the maximal
activities of the enzymes. Usually they are referred to as parameters as
they are almost always used as constants. However, as the Silicon Cell will
ultimately include higher levels of regulation, the enzyme concentrations will
vary at different conditions, thus making them variables. They can be called
boundary conditions here as they have to be measured for each condition
that the model is used, before higher regulation is incorporated.
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3.1.3 Branch reactions as boundaries
In our treatment, a third type of boundary conditions is the branch reac-
tions, although they are not classically though of as boundary conditions
in modelling terms. These are the reactions of pathways which were con-
sidered to be unimportant at the time of model construction. They are
usually excluded from the modelled network because they were assumed to
have negligible reaction rates. However, the genome-scale Silicon Cell must
eventually have all these smaller branch pathways also included as modules.
Further, biochemical systems form extensively integrated networks. Only if
the branch reactions that stem from a modelled pathway are included can
the possibly accurate rate equations be expected to simulate the realistic
situation. Put differently, by wrongly assuming zero branch reaction rates,
a kinetic model is constrained to a linear pathway flux and both the sizes of
the reaction rates and metabolite concentrations cannot represent reality if
the enzyme parameters were correct. So firstly, it is necessary to incorporate
branch pathways in order for rigorous validation to be a possibility.
How should these branch reactions be modelled? For accuracy assessment,
the aim is to simulate precisely the same effect that the rest of the network
has on the parts corresponding to the kinetic model. For the steady state
it is thus sufficient to simulate only those branch reactions that directly
consume or produce metabolite variables in the kinetic model. These can
thus be the constant measured flux values as obtained by 13C-MFA. Let
us call this set of reactions the boundary reactions. Similarly, for time-
dependent data, the time-dependent boundary reaction data (if it becomes
possible to calculate them from time-dependent metabolomics data from
a pulse experiment) could be included as an equation describing the data
as a function of time. By simulating the correct boundary reactions, any
discrepancies in simulated values to that of the data can be related only to
the errors in the kinetic parts. The boundary reactions can thus neither be
the cause of discrepancies between simulation and data, nor compensate for
errors in kinetic parts.
It is even a possibility that insufficient measurement techniques could cause
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false negative validation results, leading to the conclusion that in vitro en-
zyme measurements are erroneous, while they may be an accurate represen-
tation of the real cellular machinery. As our aim is to create a highly realistic
cell in silico, its validation should be treated in a quantitative manner and in
essence, that we adopt the view that a precise, or nearly precise description
from parts is possible. Thus, the small size of some of the branch fluxes
should not be a key to excluded them from the simulation, as it is indeed
a precisely accurate simulation that is sought after. In this way, errors in
parameters could possibly be made detectible and corrected through more
experimentation.
As accuracy assessment of models should precede the making of predictions
from them, and as the requirements are less for the purpose of validation
than for making predictions such as in MCA, considerations for prediction
are discussed in a later section.
3.2 Simulation for accuracy assessment
This section deals with matters of establishing an optimal protocol for vali-
dation based on steady state data. The first part describes a methodology
to separate a model into smaller parts for local validation, and moving the
validation criterion from fluxes towards metabolite concentrations. The sec-
ond part is dedicated to exploitation of the special properties of 13C-MFA
data.
3.2.1 Setting of steady state pathway fluxes for validation
The fact that a bottom-up approach for detailed kinetic modelling does not
use parameter fitting, implies that the simulated steady state is not nec-
essarily at the measured steady state values. Incorporation of boundary
reactions can help to put the realistic constraints on the network and en-
able the correct simulation for location of the errors in parameters. Upon
mathematical integration of the system of differential equations, one error
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will cause the whole system to predict the wrong steady state, even if all
the other equations and parameters were correct. The integrated nature
of a system of ODE’s (see figure 3.1 A) thus makes location of the errors
difficult. By separation of the individual reactions and substituting variable
concentrations with measurements (see figure 3.1 B), the reaction rates can
be simulated individually and a closer relation exists between measured con-
centrations, fluxes and enzyme kinetic parameters. This local approach was
also used for validation of the Teusink model [44]. The idea of separating a
complex model into smaller subparts was also followed for fitting parameters
to time series data in [52].
Unfortunately, metabolite concentrations are not all measurable, and the
current state of metabolomics is less quantitative than we would hope for.
Accordingly, for steady state validation, we have to use small integrated
systems of kinetics wherein their boundary concentrations are available and
of good quality. In this way, there are concentration variables in the small
integrated systems. As those concentrations could not be measured as ac-
curately as the boundary concentrations, assessment based on these concen-
trations is limited, but still useful. Concentrations could be estimated from
metabolomics data or from literature for less constringent validation, and
the predicted metabolic flux is also usable, which can likely be measured
with more confidence (see figure 3.1 C).
However, due to the problem that an integrated system is still used, even
a single error in a parameter will cause the fluxes and the concentration
predictions to be wrong. Further, validation upon flux data involves redun-
dancies, much more than with concentration data. The linear constraints
between fluxes at the steady state implicates that, for instance, in a linear
chain of reactions, there is only one flux value for comparison against many
simulated values. Also, predicted fluxes can in principle only vary between
the minimum forward Vmax and minimum reverse Vmax in any linear reac-
tion chain. On the contrary, predicted concentrations can range from (close
to) zero to infinity, which in principle makes it more likely to detect errors in
parameters based on concentrations. For steady state validation, the ideal
would thus be to move the validation criteria for small integrated systems
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Figure 3.1: The integrated nature of a system of ODE’s makes it difficult
to detect errors. Small integrated systems with boundary fluxes can be
simulated to make errors more obvious in a local assessment approach. See
text.
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Figure 3.2: A small integrated system which allows local error detection at
the steady state. The measured net flux is set, boundary fluxes are included
and assessment is based and forward and reverse reactions and on some
measured concentrations.
from fluxes to concentrations. This can be achieved by including a fixed re-
action in the small integrated system that produces the starting metabolite
and by making that metabolite a variable (see figure 3.1 D). Such a protocol
would finally result in a system as is shown in figure 3.1 E, in which the
boundary reactions are also included.
In summary, it is possible to simulate small kinetic systems, which allows
local error detection (see figure 3.2). Constraining a pathway flux to the
measured flux can be valuable in accuracy assessment as it moves the val-
idation criterion from the interdependent flux data towards the more in-
dependent concentration domain. Accuracy assessment can be carried out
on both forward and reverse reactions if the flux measurement technique
allows it. Boundary reactions must be included to put realistic constraints
on the system. In this methodology, partial metabolite data can be used
and the presence and accuracy of the metabolite data determines the size of
the simulated systems.
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3.2.2 Interesting properties of isotope labelling experiments
Many reactions are extremely reversible. Reversibility means that reactions
are simultaneously catalyzed both in the forward and reverse directions.
There are accordingly an infinite number of combinations of substrate and
product concentrations that can produce the same net reaction rate. This
means that for one set of enzyme parameters, many combinations of sub-
strate and product concentrations will all produce the same net reaction
rate, but the sizes of their forward and reverse rates will differ. This also
relates to the parameter space. For one fixed set of concentrations (which
could represent the measured values) there will be many parameter sets that
produce the same net reaction rate, but they will have different forward and
reverse rates. The case with a parameter space can be more readily related
to accuracy assessment than the case with a concentration space. As il-
lustration of the principle that reversibility causes observation deficiency of
parameters, an example is shown that illustrates the concentration space
with a fixed set of parameters. The reason is that the feasible parameter
space is nonlinear and difficult to visualize.
Consider the reversible Michaelis-Menten rate equation for a one-substrate,
one-product reaction as given below:
v =
Vmaxf
[S]
Ks
− Vmaxr
[P ]
Kp
1 + [S]
Ks
+ [P ]
Kp
(3.1)
The Haldane relationship
Keq =
VmaxfKp
VmaxrKs
(3.2)
states that there is a dependency between the equilibrium constant, satu-
ration constants and maximal forward and reverse activities. Note that the
original derivation of the reversible Michaelis-Menten rate equation (equa-
tion 3.1) features maximal activities for both the forward and the reverse
reactions. Vmaxr can be replaced by the Haldane relationship as is often
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Figure 3.3: A plot of the feasible relationship between the substrate and
product concentrations using the net flux as input. The reversible Michaelis-
Menten rate equation was set equal to a hypothetically measured net flux
of 50 mM.min−1 with 5% error. G6P was plotted by scanning F6P. The
parameters of the isomerase were obtained from the model of Teusink et
al. [44] which is available on JWS Online.
done to yield equation 3.3.
v = Vmaxf
[S]
Ks
−
[P ]
KsKeq
1 + [S]
Ks
+ [P ]
Kp
(3.3)
It is evident that there are two variables (concentrations) for one equation
(reaction rate) and thus infinitely many solutions for the variables at every
net reaction rate. To visualize this relationship, a plot was generated in
Mathematica. The coloured space in figure 3.3 shows the feasible linear
relationship that there has to be between the substrate and the product
data in order for the equation and this parameter set to be accepted as
correct at a specific measured net flux. The net flux (50 mmol.min−1.L−1)
was included with a statistical error in measurements of 5 %.
There are thus many feasible concentration sets in this space. For a certain
measured concentration set, the values could either fall inside or outside the
error margins. If it fall inside the margins, the equation and parameter set
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can be considered as accurate. If it falls outside, a different parameter set or
a different equation is necessary which will move the feasible concentration
space such that it corresponds to the measured values. Important to notice is
that there is a large probability that the measured values will fall within the
margins, as the feasible concentration space is infinite in linear combinations
of substrate and product. This relates to many feasible parameter sets and
large uncertainties in the parameter set.
We show here a partial solution to the problem of multi-dimensionality of
rate equations in order to constrain the feasible parameter space further.
Steady state isotopic tracer experiments have the potential to produce si-
multaneously the forward and reverse reaction rates. Wiechert [81] has also
shown that it is more valid to include both the forward and reverse reactions
in 13C-MFA calculations than just the net reactions, although both cannot
always be calculated due to systemic properties of the isotope labelling sys-
tem. Now, again consider equation 3.3. This equation can be rewritten in
the form
v = vf − vr (3.4)
vf = Vmaxf
[S]
Ks
1 + [S]
Ks
+ [P ]
Kp
(3.5)
vr = Vmaxf
[P ]
KsKeq
1 + [S]
Ks
+ [P ]
Kp
(3.6)
which actually states that, for example the hexose-6-phosphate isomerase
simultaneously catalyses a reaction in the forward direction that responds
positively to its own substrate glucose-6-phosphate and a reverse reaction
which reacts positively towards its own substrate, fructose-6-phosphate. In
both reactions, the substrate of the other reaction acts as a competitive
inhibitor, as the two rate equations share a common denominator. Whether
the feature of inhibition is relevant to our approach or not, both reactions
actually occur in vivo.
Figure 3.4 shows the effect of having both the forward and reverse reaction
fluxes, as is possible with isotope labelling experiments. The forward and
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Figure 3.4: A plot of the feasible relationship between the substrate and
product concentrations using the forward and reverse fluxes as inputs. The
forward and reverse reactions of the reversible Michaelis-Menten rate equa-
tion was set equal to hypothetically measured forward and reverse fluxes of
75 mM.min−1 and 25 mM.min−1, each with 5% error. The plot for the net
flux is also included. See previous.
reverse rate equations (3.5 and 3.6) was set to 75 and 25 mmol.min−1.L−1
to result in a net flux of 50 mmol.min−1.L−1, and each value was assigned
a measurement error of 5 %. The feasible concentration space is much
smaller, allowing much less uncertainty and creating a stronger case for
locating dubious parameters.
Only very recently, interest has appeared in the relationship between the
forward and reverse fluxes, concentrations, thermodynamics and enzyme ki-
netics [99]. This work suggests that the relationships could even be exploited
to validate these measurements. In line with this elegant work, it is sug-
gested in this section that the theory be used in terms of providing feasible
parameter spaces for a validation criterion.
It is also important to note that this characteristic of isotope labelling exper-
iments can only be used maximally if both the kinetic model and the isotope
labelling system are modelled in a detailed form - that is, at least in terms of
all metabolic intermediates in a pathway and as reversible reactions where
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applicable. The current application of 13C-MFA however, is not informative
enough to make full use of this idea, and was not used with our own ex-
periments. The retro-biosynthetic approach [85] normally used exploits the
fact that the isotopic labelling information in the metabolic intermediates is
stored in the monomers of biopolymers such as proteins, solving a number
of problems such as low metabolite concentrations, high turnover rates and
instability of some metabolic intermediates. However, the monomers are
only synthesized from a number of intermediates and thus the information
potential is decreased in the retro-biosynthetic approach. Apart from the
fact that only the labelling patterns of some metabolites are accessible, some
fluxes, and especially those which do not alter labelling patterns, can only
be resolved if time-dependent labelling of metabolites are accessed and con-
centrations are measured [84]. However, theorems have been derived which
relate the observed apparent exchange fluxes to dependencies between in-
dividual exchange fluxes. Using these relationships in validation, feasible
parameter spaces will become larger, but is still useful to obtain certain
bounds. From [99,100] it was also apparent that the specific enzyme mech-
anism might have an influence on the application of the theorems, therefore
work still needs to be done in this regard.
3.3 Technical considerations in flux-constrained sim-
ulation
In the sections above, the general idea of inclusion of boundary fluxes and
setting of pathway fluxes was introduced and its unique potential for accu-
racy assessment was emphasized. This use of a large number of measured
boundary fluxes and especially the setting of pathway fluxes is a novel con-
cept according to our knowledge, therefore a special effort has been made to
identify possible artefacts to be avoided. During setting of pathway fluxes,
a phenomenon was identified which was later identified as an artefact. Also,
conserved moieties in kinetic models have further implications. Based on
intuition and demonstration with matrix analysis, uncertainties of require-
ments were clarified. In the following two subsections the technicalities
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Figure 3.5: The effect of changing more than one boundary concentration
in the same linear pathway to variables. See text.
involved with constraining pathway fluxes and implications of conserved
moieties are demonstrated.
3.3.1 Considerations for constraining pathway fluxes
When pathway fluxes were set to measured values, an observation was made
with regard to the number of constraints that had been included in the
simulation. When both the reactions v0 and v4 were included (see figure
3.5), there was a dependency of the steady state concentration values on
the starting values for the intermediate metabolites. When either v0 or v4
was included, no such dependency was seen. This dependency upon starting
values is an artefact caused by the fact that the fixed v0 and v4 will always
have an equal flux value, thus an unwanted conserved concentration moiety
is formed. Matrices 3.7 and 3.8 show that, because v0 always equals v4,
the columns for v0 and v4 can be combined into one, giving the pathway
structure of a moiety (figure 3.5 B) and linearly dependent rows in the
resulting matrix 3.8. If one would include more constraints than is necessary,
an unwanted artefact is created.
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

A′(t)
B′(t)
C′(t)
D′(t)

 =


1 −1 0 0 0
0 1 −1 0 0
0 0 1 −1 0
0 0 0 1 −1

 .


v0
v1
v2
v3
v4


(3.7)


A′(t)
B′(t)
C′(t)
D′(t)

 =


1 −1 0 0
0 1 −1 0
0 0 1 −1
−1 0 0 1

 .


v04
v1
v2
v3

 (3.8)
The degrees of freedom f, of steady state fluxes, (which is also the dimension
of the [q×f ] nullspace or kernel of the matrix ker(N) ) can be calculated by
algebraic analysis of the [m×q ] stoichometric matrix N as
f = q − rank(N) (3.9)
where m is the number of variable metabolites and q is the number of
reactions [4]. It is thus necessary to set only f reaction vectors to constants
for constraining the whole system. This corresponds to the inclusion of f
constant flux setting reactions in f of these paths.
There are a number of limitations to this approach. As we exploit the setting
of reaction rates, it is inevitably only those boundary concentrations that
could feature in a stoichiometric matrix that can be used. The activators
and inhibitors do not feature in stoichiometry, and are thus irrelevant for
this purpose. Such ’stoichiometric boundary concentrations’ are generally
chosen as those rows in a stoichiometric matrix which have either only one
entry or all entries are of similar sign [51]. In general, any metabolite that
is produced or consumed by reactions can be used, it does not have to be an
extracellular metabolite. Neither does the metabolite have to be consumed
in the original kinetic model but could also be produced. Constant negative
boundary consumption reactions can constrain the flux in the same way that
positive reactions can.
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Figure 3.6: The effect of changing more than one boundary concentration
in the same reaction to variables.
A further complication arises when one reaction features more than one
suitable boundary concentration in its rate equation as in figure 3.6 A and B.
Although it is not evident that there are bi-substrate enzyme reactions that
consume extracellular metabolites, the idea is to work with small integrated
systems which are parts of kinetic modules. The start and end metabolites of
these kinetic systems are thus intracellular, where bi-substrate reactions are
actually more abundant than single substrate reactions. The many different
situations that will arise in the scope of the Silicon Cell thus deserve a generic
approach.
If cases A and B represent pathways in vivo, they obviously function dif-
ferently: In case A, metabolites X and Y are produced independently by
different reactions, therefore alterations in the metabolic state will cause
independent variations in concentrations of X and Y, whereas in B they are
always produced simultaneously. By contrast, if cases A and B represent
the simulated pathways, they seem to be different cases, like in vivo, but A
and B are actually equal: In A, the steady state flux measurements of the
two reactions in v0 must be equal due to steady state constraints, and in
B, v0 produces the two substrates simultaneously. It is not necessary that
both such boundary concentrations be changed to variables: One of the
concentrations could be a measured value. However if they were, it must
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be remembered that their time differential equations are dependent: they
have the same production and consumption rates at all times, therefore their
difference will at all times be equal to their difference at time zero. This
dependency can be illustrated by matrix equation 3.10.


X′(t)
Y′(t)
...

 =


1 −1 0 . . .
1 −1 0 . . .
0
...
. . .
...
...
. . .

 .


v0
v1
...

 (3.10)
v0 is the constant flux that is included in the reaction vector and rows
1 and 2 in the matrix were included as the boundary concentrations that
became variables. Rows 1 and 2 only contain the stoichiometric constants
for reactions v0 and v1 and zeros. Column 1 also contains only the two
stoichiometric coefficients and zeros. It can be seen that rows 1 and 2 are
positive linear combinations of each other, therefore the difference in their
concentrations will always be the same as at time zero of simulation. This
dependency of two variables means that validation potential is not maximal.
Also does it imply that both these concentrations will have to be measured
for use as starting values in the simulation, or at least that the difference
has to be included in some way. This is actually true not only for using fixed
constraining reactions, but for any such structure in a kinetic model where
the rows are positive, linear combinations of each other. Which criterion
holds the most validation information during flux constraining, using one
or two variables for such a case should be analyzed statistically, taking into
account the accuracy and availability of concentration data.
It will be found frequently that not all flux vectors can be set to measured
values, for there might be no suitable boundary concentrations in the rate
equations. Examples would be parallel pathways and loops which might not
feature stoichiometric boundary concentrations in their rate equations. Also,
some steps are modelled as irreversible steps and their products thus do not
feature in their rate equations. A fixed consumption rate cannot be used in
that case. Frequently, but not as a rule it was found that fixed consumption
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rates for setting fluxes cause problems during simulation. They could be
too fast for some of the reactions to respond, thus causing concentrations to
have negative values. Mostly, these negative concentrations cause the solve
routine to be aborted due to a division by zero in the rate equations. These
occurrences can of course be partly due to errors in the kinetic equations.
However, the starting values of concentrations could be the cause of these
errors when fixed reactions are consuming metabolites with low starting
concentrations. It is thus a non-trivial problem and one would likely have
to investigate iterative simulations with large starting concentrations (while
taking moieties into account), after prior analysis of maximal activities.
Alternatively, we could prefer fixed production fluxes over fixed consumption
fluxes.
Which one of the possibly multiple stoichiometric boundary concentrations
should be used for constraining fluxes should rely on sensitivity analysis.
Also, for some small integrated systems, it will be more informative not to
simulate the constrained fluxes, but rather to fix the metabolite concentra-
tions, and do comparisons on flux prediction. Sensitivity analysis will show
the best criteria.
3.3.2 Implications of conserved moieties when using bound-
ary reactions
Conserved moieties are formed when enzyme reactions that have more than
one substrate or product create a specific network structure that forces a
group of metabolites to always be conserved in their combined concentra-
tion values [51]. This feature of conserved moieties is true regardless of
whether the system is at a steady state or in a transient state. In numerical
simulation, this sum will at all times be equal to the sum of the starting
concentrations of those variables at time zero. This sum is thus a parameter
of the system and has to be measured accurately and used as inputs. For
steady state modelling it is sufficient to distribute the total sum over the
initial values, but for time-simulation it is important to use the individual
starting values as they were measured for the time zero. Conserved moieties
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can be detected as structural moieties in a network by Gaussian elimina-
tion of the rows in a stoichiometry matrix [51,101]. This algebraic analysis
of a metabolic network can reveal important information, even outside the
context of kinetic simulation as was well-illustrated for the human para-
site Trypanosoma brucei [101]. We investigate here the implications that
conserved moieties have for inclusion of boundary reactions. As discussed
earlier, boundary reactions can be measured and should be integrated with
the kinetic model to induce the realistic constraints. The question is now
whether there are more considerations to take into account and which arte-
facts to avoid.
The following two considerations are of importance:
1) Some of the metabolic intermediates that are consumed and produced by
the boundary reactions will form part of conserved moieties. As by definition
there is no change in the sum of metabolites in a moiety, how can boundary
fluxes be included to ensure this conservation?
2) Inclusion of fixed, measured boundary fluxes into conserved moieties can
change the model structure in specific cases such that it seems that the
conservation relations are eliminated. Does this mean that the moieties
are indeed not present and also make it unnecessary to measure metabolic
intermediates for starting conditions?
1) In the case of only one boundary reaction acting on a moiety: If the
reaction has a fixed value, whether it consumes or produces metabolites from
the moiety, the concentrations in the moiety will either increase to infinity
or diminish to zero. If the reaction is sensitive to the concentrations in the
moiety (their concentrations feature in the rate equation for the boundary
reaction), the reaction will go to equilibrium. Both cases are non-realistic
and should thus be eliminated. The situation can be detected as a single
stoichiometry entry of boundary reactions that affects a moiety. A valid set
of reaction boundary constraints to a moiety in a kinetic model thus needs to
be precisely balanced to the total kinetic moiety, if fixed boundary reactions
are used. For the case of sensitive boundary reactions, at least two reactions
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should be present of which at least one can operate in the different direction
in order to have a zero net consumption/production of the moiety.
2) It is certain that we would encounter the situation of many reactions in
a genome-scale flux model that consume and produce the intermediates of a
kinetic model moiety. For instance, the adenine nucleotide moiety consist-
ing of ADP plus ATP is usually found in realistic kinetic models of central
energy metabolism. The real situation in vivo is that there are reactions
that produce those intermediates from free adenine and others that con-
sume them, especially under growing conditions. These reactions will have
to be included as branch reactions. Some of these will be reactions that
interconvert moiety metabolites in vivo, thus the branch reactions will ac-
cordingly be precisely balanced interconversion rates (figure 3.7) which does
not affect the moiety constraints. However, there will also be other reac-
tions in vivo for synthesis and breakdown of these moiety metabolites, which
is different from an interconversion. Their presence in vivo has the effect
that the moiety constraints are released (figure 3.7). The question is: Can
incorporation of fixed, measured boundary reactions of the synthesis and
breakdown type also release the moiety constraints, and accordingly also
eliminate the need for measurement of moiety concentrations?
As can be illustrated in figures 3.7 A and B and the corresponding stoichio-
metric matrices of the metabolic networks (equation 3.11 A and B), the ma-
trices show linearly dependent rows only for the case of extra interconverting
boundary fluxes (equation 3.11 B). This means that the matrices indicate
moiety conservation only in the case of interconversion, as is directly obvious
from the scheme (B). However, in the computer simulation, the fixed syn-
thesis and breakdown fluxes must be precisely balanced, because their net
effect on the moiety must be zero. This results in the observation that the
sum constraints are not eliminated. It can also be seen that synthesis and
breakdown reaction columns in matrix A can be combined to form exactly
the same structure as matrix B with the interconversion, which therefore
implies a moiety constraint.
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Figure 3.7: Extra synthesis and breakdown reactions included as fixed re-
action rates in a conserved moiety of a kinetic model. A: as individual
reactions; B: as a single interconversion reaction.
(
A′(t)
B′(t)
)
=
(
−1 1 1 0
1 −1 0 −1
)
.


v1
v2
v3
v4

 (3.11)
(
A′(t)
B′(t)
)
=
(
−1 1 1
1 −1 −1
)
.


v1
v2
v34

 (3.12)
3.4 Dynamic pulse experiments: potential and lim-
itations
Steady state validation is limited in its information content. This is because
only a few data points of fluxes and concentrations can be used for relating to
enzyme kinetic parameters. Dynamic pulse experiments on the other hand,
produce more concentration points, and if the data is of sufficient quality,
more stringent relations can be drawn to parameters. As we explained
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earlier, the better we could separate such a kinetic system into small systems
that have sufficiently measurable boundary conditions, the better we can
validate the equations and parameters. There are however a few problems
with dynamic pulse experiments.
1) Metabolomics is not fully reliable yet in the determination of concentra-
tions due to artefacts. Although very dense time-series can now be generated
showing low second scale dynamics [102], the quantitative ability is not suf-
ficient yet for large-scale kinetics.
2) The scope of metabolites that can be observed simultaneously in a given
metabolomics technique is limited. The very large scope of new technolo-
gies such as GC×GC-TOF-MS [103] is also limited by the fact that GC
can only carry metabolites that are volatile enough to evaporate into the
GC column and still be stable. Derivatization does lower boiling points of
many more metabolites effectively to allow GC, but some larger molecules
in metabolism will not be observed in GC. Liquid chromatography (LC)
or capillary electrophoreses (CE) should then be used in stead, each with
its own problems [104]. In vivo NMR suffers from lower sensitivity and re-
solving power than MS, thus it is also limited to metabolites with larger
concentrations. Observation of dynamics throughout metabolism has been
identified as being very important and is still lacking [102].
3) Most metabolomics tools are invasive measurements and thus have no
spatial resolution. Exceptions are in vivo NMR and molecular fluorescent
resonance energy tranfer (FRET) sensors [105]. As mentioned, NMR is
unfortunately not very sensitive, thus excluding most metabolic intermedi-
ates. FRET has the potential to be very sensitive, but it has to be taken
into account that a detector protein has to be encoded in the cell for each
metabolite. Measuring thousands of metabolites simultaneously with FRET
is therefore unlikely. Further, binding of metabolites to FRET sensors has
kinetics of its own to take into account.
4) Fundamentally, the organism must have genetically expressed transporters
for a substrate in order for it to be used as a pulse agent. A good example
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of one is glucose, which is frequently used to perturb glycolysis. After a
glucose pulse, dynamics of metabolites in the immediate pathways, such as
the EMP and HMP pathways will likely be readily observed and links to
parameters established with high confidence. However, further away, the
dynamics will be much slower, giving time for signal transduction and gene
regulation to act on the enzymes. The direct link to enzyme parameters
is thus diminished. Also, for many metabolic intermediates there are no
transporters and can thus not be used for the purpose of directly perturbing
dynamics around them on the cellular map.
5) Sometimes the transport reaction or any reaction at the start of a reac-
tion chain could have a maximal reaction rate significantly lower than the
reactions further down the pathway. For in vivo validation procedures this
poses a problem for there is no way to induce large reaction rates by that
route using the pathway substrate.
6) Substrate pulses might not produce enough simultaneous variations in
concentrations that affect one reaction, therefore insufficient perturbations
are made in the concentration dimensions.
There is thus a need to improve metabolomics techniques to enable more
quantitative dynamic experiments, which lies largely in the realm of analyt-
ical technology. However, even after advances in these technologies, as well
as combining them, fundamental problems of dynamic pulse experiments
will persist that limits the information content.
In dynamic pulse experiments, iterative simulations are carried out with a
large number of parameter sets. This data not only has associated measure-
ment errors, but also lacks in enough independent variations in substrate
and product concentrations around the enzymes. Of special interest to us
is that the reversibility of enzyme reactions plays a large role in making
it impossible to extract the parameter values with good confidence, or to
make accurate validation possible. Accordingly, large feasible parameter
spaces are the result. It was explained in section 3.2.2 that the reversibility
of enzyme reactions and the extra variables and parameters that it brings
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makes is impossible to obtain small parameter spaces when using only con-
centration and net flux data. It was also explained that the data of forward
and reverse fluxes from 13C-MFA might be used to significantly reduce the
feasible parameter spaces. It is now argued that these parameter spaces
from steady state flux and metabolomics experiments, especially those from
13C-MFA should be used in combination with the parameter spaces from
pulse experiments. Logically, the intersection between the two sets will be
smaller than either of the two sets. The two types of experiment might thus
each produce information that the other could not produce for some reason.
It will be interesting to see the increased information from the completely
general scenario - that of metabolic and isotopic non-steady state pulse ex-
periments. All the features of both steady state MFA and pulse experiments
are thus oncorporated into one theory. In the context of the arguments given
in this section and in section 3.2.2, it is expected that in this way, the pa-
rameter space can be reduced maximally. In this regard it is also obvious
why the metabolomics tools that lend themselves to tracing isotopes - NMR
and MS - have a larger information potential than other methods.
As a result of realization of this potential, the author also experimented
with explicit modelling of isotopomers in simulations with detailed enzyme
kinetic models. This work is still at the initial stages, therefore a description
is not given here as it will form part of future investigation.
Genome-scale flux/kinetic identifiabiliy with isotopes and pulse experiments
will however prove difficult because of problems 4-6 mentioned earlier, as well
as the fact that flux identifiability is diminished with an increasing number of
label mixing steps. Modelling of the slower reaction networks will extensively
depend on kinetics obtained in vitro. Hopefully, the new knowledge of in
vivo kinetics of the fast central metabolism could teach us about the in vivo
factors such as molecular crowding and chanelling such that we can design
novel high-throughput in vitro assay methods for modelling a Silicon Cell.
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3.5 Simulation for prediction: Metabolic Control
Analysis
If we want to make predictions from the model, like in the form of MCA,
boundary reactions have to be sensitive to the intermediates they consume
or produce. Such boundary reactions are actually representations of con-
nected pathways in a global cellular network, thus incorporating only the
sensitivities of the first connected enzyme reaction does not complete the
picture. It might be a good approximation for describing the branch path-
way if this first reaction is irreversible, as metabolic control is increased in
such a step. If one would leave out the boundary reactions, a normal MCA
could be done. However, the result will be at a steady state that might be
far from the observed phenotype. Systemic property analysis at an unreal-
istic steady state simulation makes no sense at all, even though MCA may
seem to be an attractive option.
A solution to this problem might be presented by a framework for MCA
recently developed to incorporate uncertainties in enzyme parameters and
measurements of fluxes and concentrations [63]. For the dubious parameters
(or for all parameters, concentrations and flux measurements), probability
distributions are generated and Monte Carlo Sampling is used to generate
distributions of control properties through the matrix-based MCA formu-
lation. The specific type of kinetic model that the authors used is the
(log)linear type of model. It is important to note that the type of model
the authors used is not important for the argument, and that it is not sug-
gested here that we use the (log)linear approach which is less detailed than
the in vitro approach. It is more important that we recognize the useful-
ness of a framework for incorporating uncertainties in both enzyme kinetic
parameters and metabolic measurements.
(Log)linear kinetic models have simple rate equations which are fitted to
metabolic data. Thus, the simulated fluxes and concentrations are those of
the measurements. The MCA is thus inevitably carried out at the correct
simulation results. The matrix-based formulation of MCA generates con-
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trol and regulation properties only via elasticities (sensitivies of reactions
towards concentrations) at a measured or assumed flux and concentration
distribution. For the detailed kinetic models that we want to use in the Sili-
con Cell, the same matrix-based MCA formalism is valid. The elasticities at
a simulated steady state can be obtained from the rate equations and used as
in the (log)linear formalism. However, as we do not fit our models to data,
the simulated concentrations and fluxes of the kinetic model will not be the
same as the measured values, due to two reasons: 1) there are errors present
in the enzyme rate equations and parameters, and 2) the absence of mod-
elled boundary reactions that are present in vivo. Without some degree of
parameter fitting, it is unlikely that the detailed kinetic model will precisely
simulate the measured values in all dimensions. Therefore, the formalism
for Monte Carlo Simulation MCA can thus not be used in exactly the same
form as in [63], at least not in terms of the error distributions for metabolic
measurements. A different form of the formalism will have to be used, in
which inaccuracies in the simulation penalize the confidence in control and
regulation properties.
Whether the model accurately simulates the correct values upon the first
attempt or after many model improvement steps, for realistic MCA we will
have to get to a simulated steady state that closely resembles the measured
values. Inclusion of the boundary reactions in the kinetic model and in-
evitably also in the MCA formalism is the first step towards obtaining a
more realistic simulation. Model improvement follows by more in vitro and
dynamic substrate pulse experiments, which should result in closer resem-
blance of the measured fluxes. For MCA, we may need to proceed as follows:
1. Obtain concentration and flux measurements through the system.
2. Carry out the numerical simulation with the measured boundary con-
centrations and reactions included in the model.
3. Analyse the accuracy of the simulation. If the model does not pre-
dict satisfactory results, improve until satisfactory. Improvements can
include reassessing the validity of the in vitro experiments, extra in
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vitro measurements (especially maximal activity values), reassessment
of the conversion factors used in flux and in vitro experiments, etc.
The accuracy assessment and improvement will also largely depend on
time series data from dynamic pulse experiments.
4. Create the matrix-based MCA formulation (as in [63]) with the elastic-
ities at the steady state simulation (at which the steady state variables
will not necessarily be precisely those of the measurements). For the
boundary reactions, estimate realistic distributions for elasicities, con-
sidering measured fluxes, concentrations, available kinetic parameters
and thermodynamics.
5. Generate control and regulation distributions.
It is likely that the branch pathways, which have smaller fluxes, will have
less flux and concentration control over the central pathways which catalyze
larger fluxes, as explained by Snoep et. al. [106]. Therefore it is likely
that estimation of these elasticities are not as crucial as for the rest of the
model. It is suggested here that the sensitivities of boundary conditions
can be modelled with probability distributions to generate control features
with Monte Carlo Simulation. It should be evident that this gives better
understanding of the control coefficients, taking into account the calculated
or assumed uncertainties.
Chapter 4
Kinomics
As was mentioned in Chapter 1, a modular approach was suggested for
the Silicon Cell Initiative and a work plan was provided for building con-
text independent modules [66]. Such models are currently stored in model
databases such as JWS Online (http://jjj.biochem.sun.ac.za). The aim is
now to start validating them separately on a large-scale reference physiomic
dataset before they can be linked to create larger models. As was explained
in Chapter 3, the integrated nature of cellular systems and special structural
considerations make this integration process rather complex. Further, the
available modules are full of simplifications of various forms. In response
to these findings, a prototype software program was designed by the author
that is useful for further progress in high-accuracy large-scale modelling and
validation. In order to avoid repetitive reference to the software as ’the
software’, we rather call it Kinomics.
4.1 Main features and uses
In overview, Kinomics is to be used for getting kinetic modules from the
JWS Online database into a form which allows:
1. numerical integration to simulate metabolic dynamics or the steady
state.
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2. combining of individual modules with metabolite and reaction data as
boundary conditions or as validation data.
3. extraction and individual simulation of any kinetic subsystem.
4. combining of modules to form larger models.
5. visual access to the modelling process.
6. intervention at multiple stages.
Mathematica is a symbolic algebra system with a vast array of high-level
functions. What makes this environment particularly useful in Kinomics
is its satisfactory symbolic manipulation of large equations and their dis-
play. As the aim was not a complete simulation environment such as the
excellent software programs PySCeS [107], Virtual Cell [108], Jarnac [109],
Copasi [110], CellDesigner [111] and E-Cell [112], it should thus be devel-
oped further to work in parallel with other simulation environments to ad-
dress principles which the other software programs might not have focused
on. The complications encountered (described in the previous chapter) en-
couraged a very robust and simple design in which we can deal with the
simplifications in the modules.
The modelling process is annotated throughout by the text cell annotation,
describing what each cell does. A decent level of understanding of the work-
ings of the program is at this stage necessary to use Kinomics. Automation
is built in to eliminate errors that occur almost inevitably with large kinetic
models.
As an example of its application, Kinomics was used to integrate a kinetic
module from the JWS database into a significantly larger reaction network
of central carbon metabolism, which was also our network for flux measure-
ments, as is illustrated in figure 4.1. Kinomics makes use of a number of
spreadsheets for flux and concentration input and for editing of the structure
of the model. Model outputs are also written to spreadsheets. The Mathe-
matica environment itself is used for a number of concise choice inputs and
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Figure 4.1: Metabolic pathways in central carbon metabolism of the yeast
Saccharomyces cerevisiae. Grey arrows are measured fluxes in the flux
model. Black arrows are reactions in a kinetic model.
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for editing of rate equations. Both spreadsheets and the Mathematica envi-
ronment are customizable and the simple possibility of using colours makes
them both more functional for editing. We will now give a brief outline of
the principles involved by using the example of the Teusink model.
4.2 The internal structure of Kinomics
As the software is rather simple in its design, it can readily be described in
terms of a flow diagram (figure 4.2) to show the order of dependencies of
structure, variables and parameters as they will be encountered when using
the software. Figures 4.4 to 4.8 are amplifications of the spreadsheets in
figure 4.2.
Kinetic modules are downloaded from the JWS database in PySCeS (.psc)
format to a personal folder, as indicated by number (1) in the flow diagram.
Here, further choices are made with regard to which of the modules should be
used for simulation. Information is extracted from the text files and various
.xls spreadsheets are generated for further editing. (2) is an ODE based form
that contains all information with regard to the metabolic species modelled
(see also figure 4.3). This format will ultimately lead to the generation of the
stoichiometric network structure. Kinetic modules are added automatically
onto the same spreadsheet and thus modules can be connected by copy
& paste of spreadsheet cells in a robust manner. The default stoichiometry
values can also be replaced with names in order to test variable stoichiometry
as is shown here for the example of the Teusink model. For example, the
stoichiometry coefficients of the succinate producing reaction, vSuc, were
replaced by variable names for the individual metabolites that the reaction
consumes and produces.
In (3), the names of the branch reactions that consume and produce the
species in the kinetic model (the boundary reactions) are copied from out-
put spreadsheets from the large flux measurement model (see also figure
4.4). In the current study, the measured flux outputs from the 13C-MFA
program, FiatFlux, was processed to spreadsheets. In the FiatFlux algo-
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Figure 4.2: Legend on next page.
Chapter 4. Kinomics 68
Figure 4.2: Flow diagram of dependencies in Kinomics. Green boxes rep-
resent spreadsheets, orange represents Mathematica data forms, solid grey
lines represent program algorithms, and dashed grey lines represent manual
input by the user. (1,2) Kinetic module files are converted to an ODE-based
spreadsheet form. (3,4,5) The user copies and pastes boundary reaction
names from flux output files onto the ODE-based spreadsheet. (6) Arbi-
trary names are given for constraining pathway fluxes. (7) Stoichiometric
matrices and reaction vectors are generated. (8) A list of enzyme parame-
ters, (9) constant/variable choices, and (10) boundary/intial concentration
values are exported to a spreadsheet, to be used as basis for a series of simu-
lations. (11) The kinetic rate equations are kept in Mathematica input form.
Transforms are created for (12) rate equations, (13) variables, (14) bound-
ary concentrations and (15) enzyme parameters. (16) The user can specify
transforms to overrule any of the previous. (17) Constant/variable choices
are used to select rows of kinetic model matrices (19) and rows in boundary
matrices (20), which are parameterized by data from flux calculations. (21)
After a moiety balance check, ODE’s are created and numerically simulated.
(22, 23) Outputs are reported in spreadsheet form which links kinetic sim-
ulation results to the larger flux model. Linkage is manually created via
spreadsheets for reactions (24) and metabolomics (25). (26) All simulation
inputs are included in the output form, and simulations can be repeated at
a later stage (27).
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0 0 0 0 0 0
0 0 0 0 -1 vFLUXETOH
0 0 0 0 -1 vFLUXSUCC
0 0 0 0 1 vFLUXGLCo
0 0 0 0 -1 vFLUXGLY
-1 Biomassglucose -1 Balanceglucose 0 0
-1 BiomassG6P -1 BalanceG6P 0 0
-1 BiomassF6P -1 BalanceF6P 0 0
0 0 0 0 0 0
-1 BiomassT3P -1 BalanceT3P 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
-1 BiomassPEP -1 BalancePEP 0 0
-1 BiomasscytPYR -1 BalancecytPYR 0 0
-1 Biomassacetaldehyde -1 Balanceacetaldehyde 0 0
1 BiomassNADH 1 BalanceNADH 0 0
-1 BiomassNADH -1 BalanceNADH 0 0
-1 BiomassATP -1 BalanceATP 0 0
1 BiomassATP 1 BalanceATP 0 0
0 0 0 0 0 0
biomassfluxconstraints 0 balanceconstraints 0 ratesetconstraints end
CO2
ETOH
SUCC
GLCo
GLY
GLCi
G6P
F6P
F16P
TRIO
BPG
P3G
P2G
PEP
PYR
ACE
NAD
NADH
ATP
ADP
AMP
Figure 4.5: Module exportfulldynamicnetwork: biomassfluxconstraints, bal-
anceconstraints and ratesetconstraints. A part of the ODE-based network
format the user has to paste from net metabolic flux data, which becomes
boundary reactions. The ratesetconstraints have arbitrary names and rep-
resent a measured net flux value through the pathway.
rithms, which are based on 13C-constrained flux balancing, constraints are
based on metabolite balances, flux ratios and limits of flux ratios (see section
2.1 and [87]). To calculate net fluxes, optimization is applied to minimize
metabolite balances. Accordingly, metabolite balances are not necessarily
zero, indicative of either error in measurements, or in the network struc-
ture used, or as net reaction rates calculated intentionally by not balancing
a metabolite. We interpreted all balances as branch fluxes that consume
(negative balances) or produce (positive balances) metabolites. Accordingly,
these were included in the boundary reactions (4)(figure 4.5). In the Fiat-
Flux methodology, the biomass fluxes of each metabolite are also included,
which are calculated from the requirements of each metabolite for biomass,
multiplied by the growth rate. These biomass fluxes were also included in
the boundary reactions (5)(figure 4.5).
Step (6) is included to allow the user to set pathway fluxes in the kinetic
model (see figure 4.5) as was described in Chapter 3. In (7), stoichiometric
matrices are generated for each of the blocks in the editing form (edited-
kinetics, measuredfluxconstraints, biomassfluxconstraints, balanceconstraints
Chapter 4. Kinomics 72
and setrateconstraints), each with its reaction vector. The matrices all have
the same number of rows (biochemical species), which is the total number
of species modelled, both the boundary concentrations and the variables.
A spreadsheet (variationtables) is automatically generated that contains the
default enzyme parameters (8), a combined set of boundary concentrations
or initial concentrations (9), and a list specifying whether each of the species
should be treated as a variable or a boundary concentration (10) (figures
4.6 and 4.7). The spreadsheet form allows multiple simulations with various
parameter values and variable/boundary choices. The latter feature makes
it possible to simulate any subnetwork in a kinetic model.
Rate equations (see Appendix A) are obtained from the modules and kept
in the Mathematica extended mathematical representation format (11) as
inputs that can be edited manually in a visually understandable manner.
Like the above mentioned spreadsheet formats, once this format has been
created, it is no longer needed to extract information from .psc module files
as all the information is stored.
The symbolic language of Mathematica allows the convenient functionality
of transformation rules (/. →). In (12, 13, 14, 15), transforms are created
automatically that are used to replace reaction names with rate equations,
and to transform rate equations with the relevant variable names, boundary
concentration values, and enzyme parameter values. (16) is a step for man-
ually creating transformation rules which can overrule any of the previous
transforms, thus allowing the user to change anything with regard to indi-
vidual steps, such as setting certain reactions equal to a value (for instance
zero), changing rate equations, altering boundary concentration values to
a time-dependent equation describing data, changing stoichiometry values,
etc.
In (17), the choice of variables and boundary concentrations are used to
obtain the relevant rows of each of the five stoichiometric matrices that cor-
respond to the metabolite variables. Transforms are created automatically
from FiatFlux output spreadsheets (18) that are used to parameterize the
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entity original original,vSUCATP=4 original+MYHPLC
0 original extras original extras original extras
0 original more original more original more
VmGLT 97.264 97.264 97.264
KeqGLT 1 1 1
KmGLTGLCo 1.1918 1.1918 1.1918
KmGLTGLCi 1.1918 1.1918 1.1918
alpha 0.91 0.91 0.91
VmGLK 226.452 226.452 226.452
KeqGLK 3800 3800 3800
KmGLKGLCi 0.08 0.08 0.08
KmGLKG6P 30 30 30
KmGLKATP 0.15 0.15 0.15
KmGLKADP 0.23 0.23 0.23
VmPGI 339.677 339.677 339.677
KeqPGI 0.314 0.314 0.314
KmPGIG6P 1.4 1.4 1.4
KmPGIF6P 0.3 0.3 0.3
VmPFK 182.903 182.903 182.903
gR 5.12 5.12 5.12
L0 0.66 0.66 0.66
KmPFKF6P 0.1 0.1 0.1
CPFKF6P 0 0 0
KmPFKATP 0.71 0.71 0.71
CPFKATP 3 3 3
KPFKAMP 0.0995 0.0995 0.0995
CPFKAMP 0.0845 0.0845 0.0845
KiPFKATP 0.65 0.65 0.65
CiPFKATP 100 100 100
KPFKF26BP 0.000682 0.000682 0.000682
CPFKF26BP 0.0174 0.0174 0.0174
KPFKF16BP 0.111 0.111 0.111
CPFKF16BP 0.397 0.397 0.397
VmALD 322.258 322.258 322.258
KeqALD 0.069 0.069 0.069
KmALDF16P 0.3 0.3 0.3
KmALDGAP 2 2 2
KmALDDHAP 2.4 2.4 2.4
KmALDGAPi 10 10 10
VmGAPDHf 1184.52 1184.52 1184.52
VmGAPDHr 6549.68 6549.68 6549.68
KmGAPDHGAP 0.21 0.21 0.21
KmGAPDHBPG 0.0098 0.0098 0.0098
KmGAPDHNAD 0.09 0.09 0.09
KmGAPDHNADH 0.06 0.06 0.06
VmG3PDH 70.15 70.15 70.15
KeqG3PDH 4300 4300 4300
KmG3PDHDHAP 0.4 0.4 0.4
KmG3PDHNADH 0.023 0.023 0.023
KmG3PDHNAD 0.93 0.93 0.93
KmG3PDHGLY 1 1 1
VmPGK 1306.45 1306.45 1306.45
KeqPGK 3200 3200 3200
KmPGKBPG 0.003 0.003 0.003
KmPGKP3G 0.53 0.53 0.53
KmPGKADP 0.2 0.2 0.2
KmPGKATP 0.3 0.3 0.3
VmPGM 2525.81 2525.81 2525.81
KeqPGM 0.19 0.19 0.19
KmPGMP3G 1.2 1.2 1.2
KmPGMP2G 0.08 0.08 0.08
VmENO 365.806 365.806 365.806
KeqENO 6.7 6.7 6.7
KmENOP2G 0.04 0.04 0.04
KmENOPEP 0.5 0.5 0.5
VmPYK 1088.71 1088.71 1088.71
Figure 4.6: Module variationtables A. Each column in the list corresponds
to a set of enzyme parameters. The list is initially obtained from the files
on JWS Online. See text.
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KeqPYK 6500 6500 6500
KmPYKPEP 0.14 0.14 0.14
KmPYKPYR 21 21 21
KmPYKADP 0.53 0.53 0.53
KmPYKATP 1.5 1.5 1.5
VmPDC 174.194 174.194 174.194
KmPDCPYR 4.33 4.33 4.33
nPDC 1.9 1.9 1.9
VmADH 810 810 810
KeqADH 0.000069 0.000069 0.000069
KmADHACE 1.11 1.11 1.11
KmADHETOH 17 17 17
KmADHNADH 0.11 0.11 0.11
KmADHNAD 0.17 0.17 0.17
KiADHACE 1.1 1.1 1.1
KiADHETOH 90 90 90
KiADHNADH 0.031 0.031 0.031
KiADHNAD 0.92 0.92 0.92
KATPASE 39.5 39.5 39.5
KSUCC 21.4 21.4 21.4
F26BP 0.02 0.02 0.02
KeqAK 0.45 0.45 0.45
KeqTPI 0.045 0.045 0.045
VmAK 65000 65000 65000
KGLYCOGEN 6 6 6
KTREHALOSE 2.4 2.4 2.4
chooseconstvarstablechooseconstvarstablechooseconstvarstablechooseconstvarstable
CO2 const const const
ETOH const const const
SUCC const const const
GLCo const const const
GLY const const const
GLCi var var var
G6P var var var
F6P var var var
F16P var var var
TRIO var var var
BPG var var var
P3G var var var
P2G var var var
PEP var var var
PYR var var var
ACE var var var
NAD var var var
NADH var var var
ATP var var var
ADP var var var
AMP var var var
valueconstvarstablevalueconstvarstable valueconstvarstablevalueconstvarstable
CO2 NA NA NA
ETOH 50 50 5.046666921
SUCC NA NA NA
GLCo 50 50 26.87373596
GLY 0.15 0.15 1.210438787
GLCi 0.087 0.087 0.087
G6P 1.39 1.39 1.39
F6P 0.28 0.28 0.28
F16P 0.1 0.1 0.1
TRIO 5.17 5.17 5.17
BPG 0 0 0
P3G 0.1 0.1 0.1
P2G 0.1 0.1 0.1
PEP 0.1 0.1 0.1
PYR 3.36 3.36 3.36
ACE 0.04 0.04 0.04
NAD 1.2 1.2 1.2
NADH 0.39 0.39 0.39
ATP 1 1 1
ADP 1 1 1
AMP 2.1 2.1 2.1
Figure 4.7: Module variationtables B. Together with the enzyme parame-
ters there are two sections: one which specifies the choice whether to make a
modelled species a variable or a constant in the model, and one which spec-
ifies the value of either the starting condition or the boundary condition,
based on the above choice. See text.
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boundary reaction matrices corresponding to the measured fluxes, biomass
fluxes and balance fluxes that consume or produce the metabolite variables.
In (19), the transforms for the rate equations are used to transform the ki-
netic model matrix to a set of differential equations containing kinetic rate
equations.
The idea behind the creation of individual matrices and vectors and the use
of transforms is that it gives the user control over the process. The net-
work is built from parts and transformations are applied stepwise, therefore
it is possible to test, for instance, the effect of constraint reactions on the
kinetic reaction network. An algorithm was implemented to test whether
the boundary reactions have any effect on the conserved concentration moi-
eties. The algorithm makes use of the method described in [51] by which an
identity matrix is appended to the stoichiometric matrix and Gaussian elimi-
nation is applied to obtain conserved moieties. The parameterized boundary
reactions (20) are then applied to all the species in the moiety and it can be
established whether there is any net consumption or production to a moiety.
It is for instance necessary that the production rates of moiety species must
be precisely equal to their consumption rates, as was described in Chapter
3.
An algorithm was created that checks whether a certain reaction can take on
a certain measured flux. This could also be done by inspection of Vmax val-
ues, however this parameter might not feature in all rate equations. In most
cases, the reverse maximal activities also do not feature explicitly, as this
parameter is usually replaced by the Haldane relationship. Accordingly, an
algorithm was built which makes use of a totally generic approach by which
it is not necessary to specify a maximal activity in a specific direction, and
thus makes automation possible. The algorithm is based on using all com-
binations of variables featuring in a rate equation, where the concentration
variables are replaced with near-zero and near-infinity values. The reaction
rates are then calculated to obtain the limits of a reaction.
If it is found that the constraints applied by the boundary reactions are
feasible, all the transformations are applied and the system of differential
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equations are obtained (21) which is numerically integrated in the Mathe-
matica algorithm NDSolve. If a steady state is reached, the reaction rates
(22) and the concentrations (23) at the end time can be written to an output
spreadsheet file.
The comprehensive output file is created via two other spreadsheet forms
which link reactions and biochemical species in the kinetic model to those
in the larger network of reaction and concentration data. For the reaction
data spreadsheet (relateMFAtoKinetics) and the metabolomics spreadsheet
(relateMetabolitestoKinetics) the reaction and species vectors are obtained
automatically from the kinetic model integration spreadsheet and the data
spreadsheets (24, 25). By drag & drop, the user then lines up the kinetic en-
tity with the data entity, as well as coefficients to relate them quantitatively
(figure 4.8 A and B). Figure 4.8 A shows the list for linking the outputs
of the flux-constrained kinetic model to the values of the flux model. The
same names of the boundary reactions thus occur in both reaction columns.
A relational coefficient is specified in the column between the lists which
describes the numerical relationship between a simulated flux and a mea-
sured flux. All boundary fluxes are related with a coefficient of 1. Other
coefficients could have different values, for instance if the convention of sto-
ichiometry is different between the data model and the kinetic model. The
simulated fluxes can also be a combination of measured fluxes, in the case
where the pathway structures in the flux model and the kinetic model are de-
scribed differently. For instance, vGAPDH and vPGK in the kinetic model
are represented by the sum of Measv12 and Measv8 in the data model. In
the original flux model, Measv8 directly consumes T3P and not 3PG, as is
shown in figure 4.9 A (reaction F8). In the original flux model, the stoi-
chiometry convention thus describes the production of PEP as in the kinetic
model, but not the consumption of T3P. The consumption of T3P to form
3PG (which is vGAPDH and vPGK in the kinetic model) does not exist in
the flux model, but can be described as Measv12 + Measv8. The robustness
in this manual linkage step thus makes it possible to handle this situation
of simplification, to quantitatively link the two model types in the correct
way, as is shown in figure 4.9 B.
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GLCi 1 datGLCi
G6P 1 datG6P
F6P 1 datF6P
F16P 1 datF16P
TRIO 1 datTRIO
BPG 1 datBPG
P3G 1 datP3G
P2G 1 datP2G
PEP 1 datPEP
PYR 1 datPYR
ACE 1 datACE
NAD 1 datNAD
NADH 1 datNADH
ATP 1 datATP
ADP 1 datADP
AMP 1 datAMP
CO2 1 datCO2
ETOH 1 EXethanol
SUCC 1 EXsuccinate
GLCo 1 EXglucose
GLY 1 EXglycerol
A
B
vFLUXGLCo 1 Measv1glcuptake
vGLT 1 Measv1glcuptake
Biomassglucose 1 Biomassglucose
Balanceglucose 1 Balanceglucose
vGLK 1 Measv1glcuptake
vGLYCO 1 nc
vTreha 1 nc
Measv3ZWF 1 Measv3ZWF
BiomassG6P 1 BiomassG6P
BalanceG6P 1 BalanceG6P
vPGI 1 Measv2PGI
Measv6TKL 1 Measv6TKL
Measv7TAL 1 Measv7TAL
BiomassF6P 1 BiomassF6P
BalanceF6P 1 BalanceF6P
vPFK 1 Measv4PFK
vALD 1 Measv4PFK
Measv5TKL 1 Measv5TKL
BiomassT3P 1 BiomassT3P
BalanceT3P 1 BalanceT3P
vG3PDH 1 Measv27GPD
vFLUXGLY 1 Measv27GPD
vGAPDH 1 Measv12TDH + Measv8SER
vPGK 1 Measv12TDH + Measv8SER
Measv8SER 1 Measv8SER
vPGM 1 Measv12TDH
vENO 1 Measv12TDH
Measv22PCK 1 Measv22PCK
BiomassPEP 1 BiomassPEP
BalancePEP 1 BalancePEP
vPYK 1 Measv13PYR
Measv23 1 Measv23
Measv31 1 Measv31
BiomasscytPYR 1 BiomasscytPYR
BalancecytPYR 1 BalancecytPYR
vPDC 1 Measv33
Biomassacetaldehyde 1 Biomassacetaldehyde
Balanceacetaldehyde 1 Balanceacetaldehyde
vADH 1 Measv26ADH
vFLUXETOH 1 Measv26ADH
vSUC 1 Measv25ALD
vSUC 1 Measv24ACS
vSUC 1 Measv30
vSUC 1 Measv15CIT
vSUC 1 Measv16ACO
vSUC 1 Measv17KGD
vFLUXSUCC 1 Measv17KGD
Measv10SHM 1 Measv10SHM
Measv14PDA 1 Measv14PDA
Measv18SDH 1 Measv18SDH
Measv19MDH 1 Measv19MDH
Measv34TH 1 Measv34TH
Measv9SHM 1 Measv9SHM
Measv11GCV 1 Measv11GCV
Measv32Atmung 1 Measv32Atmung
BiomassNADH 1 BiomassNADH
BalanceNADH 1 BalanceNADH
vATP 1 nc
BiomassATP 1 BiomassATP
BalanceATP 1 BalanceATP
vAK 1 nc
Figure 4.8: (A) Module relateMFAtoKinetics links the simulated flux values
of the flux-constrained kinetic model to the values of the flux data model.
A relational coefficient is specified in the middle column describing the re-
lationship between a simulated and a measured flux. The simulated fluxes
can also be a combination of measured fluxes, in the case where the mean-
ing of a certain reaction in the data model differs from that in the kinetic
model. (B) Module relateMetabolitestoKinetics. This relates the simulated
concentration values in the kinetic model with metabolomics data through
a relational coefficient, or as a combination of data values.
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F12/vPGM
F12/vENO
NADH
SERF8
T3P
PEP
VGAPDH
VPGK
NADH
NAD
ATP
ADP
NADH
SER
F12-F8/vGAPDH
F12-F8 /vPGK
F12/vPGM
F12/vENO
F8
T3P
PEP
NADH
NAD
ATP
ADP
2PG
BPG
3PG
2PG
BPG
3PG
A B
Figure 4.9: (A) The simplified pathway structure used in the flux model.
The serine branch consumes T3P. (B) The serine branch was included in
Kinomics as a boundary reaction consuming 3PG, as it occurs in vivo.
Multiple simulation outputs are reported next to one another, as well as all
information necessary (26) to carry out the same simulation again. This
information can automatically be reloaded (27) and used for further simu-
lations when starting a new Mathematica session, and the results written
to the same spreadsheet next to the previous results. Large output files can
thus be created and the spreadsheet format allows post-simulation analysis.
Kinomics was designed by the author in its entirety and is already functional.
However, it was written as a prototype program for integration and is not
yet a user friendly standalone program at this stage. The useful features of
the symbolic language were exploited. It seems that graphical user interfaces
will be necessary to make working with large network structures and many
parameters less intimidating. It could be efficient to use the J/Link extension
package to Java that is available in Mathamatica. Also, as bioinformatics
will eventually have to be a feature in building the Silicon Cell, extensions to
Python could be very useful. Python is also being used at our institute for
writing the PySCeS [107] modelling software. Model building at the genome
scale with thousands of reactions will definitely need extensive computer
assistance and many functional links through bioinformatics.
Chapter 5
13C-metabolic flux
experiments
Kinetic modules must be validated against an extensively characterized ref-
erence physiomic dataset. For genome-scale kinetic modelling, more infor-
mative experiments still have to be designed, which will include various
principles such as metabolomics, isotope labelling experiments and dynamic
pulse experiments. To illustrate the flux-constrained approach (see Chapter
3) with relevant experimental data, 13C-MFA experiments were conducted
for the yeast, focussing on the central carbon metabolism. The aim here was
more to learn the technique of 13C-MFA than it was to obtain new knowl-
edge of yeast physiology. Experimental protocols for 13C-MFA had already
been well-defined [113].
5.1 Experimental procedures
We calculated metabolic fluxes through the central metabolic pathways of
yeast with the previously described flux model ( [113,114], figure 4.1) with
FiatFlux [95] which is based on 13C-constrained flux balancing. Overall, our
experimental setup of choice was to use small aerobic and anaerobic batch
cultures of 20 mL in which labelling patterns were obtained with GC-MS,
while external metabolites were determined with HPLC.
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The choice to use both aerobic and anaerobic conditions for the yeast was
due to a number of considerations with regard to the experimental conditions
for which the kinetic model of glycolysis [44] was constructed. The authors
used compressed yeast (Koningsgist) for determination of maximal enzyme
activities and other enzyme parameters. Their model was validated against
glucose run-out experiments of compressed yeast in phosphate buffer. To
eliminate reactions through metabolic branches that consume intermediates
from the network defined by the kinetic model (fermentative metabolism of
glucose), the medium was without a nitrogen source, to eliminate growth
reactions. It was also anaerobic to eliminate electron transport and oxidation
of NADH.
It can be argued that the ready-grown compressed yeast, which is industri-
ally produced, would have an enzyme activity profile characteristic of aerobic
cultivation. Industrial cell biomass production is usually aerobic due to less
by-product formation, which is wasteful. It is however uncertain whether
the yeast might have adapted in storage to other conditions and both aerobic
and anaerobic conditions were applied in our study.
More important is our choice of using not compressed yeast, but a very
relevant laboratory strain CEN.PK 113-7D, and growing conditions. The
idea is in fact not to keep simplifying the metabolic network by applying
unusual culture conditions as is often done in kinetic modelling studies,
but rather to extend the network by using rapidly growing, healthy yeast
in a more complex medium. Such conditions will probably also stimulate
more interest in the project as they are more realistic and applicable. One
can assume that kinetic parameters in the two strains are more or less the
same, but that maximal activities would have to be measured later for more
accurate modelling.
In general, procedures were as described in [113] except for a few changes
that are specified here.
Chapter 5. 13C-metabolic flux experiments 81
5.1.1 Growth conditions
The strain Saccharomyces cerevisiae CEN.PK 113-7D was grown in small
aerobic and anaerobic batch cultures. For aerobic growth, 20 mL cell cul-
tures in 150 mL Erlenmeyer flasks were used on a rotary shaker at 250 rpm
and kept at 30◦C. For anaerobic growth, 20 mL cell cultures in 25 mL Er-
lenmeyer flasks were used on a rotary shaker at 150 rpm at 30◦C. In the
aerobic cultures, caps were made from loose-fitting aluminium foil in or-
der to allow optimal gas exchange. In the anaerobic cultures, caps were
made from tight-fitting thick silicon caps originating from 60 mL syringes
through which needles were punched for flushing the headspace with nitro-
gen gas. The gas was bubbled through water first to reduce evaporation
in the culture vessels. Although oxygen readily diffuses through silicon,
it was assumed that the combination of nitrogen flushing, slower shaking,
the smaller vessel, and rapid initial oxygen uptake of the yeast should have
greatly reduced the dissolved oxygen concentration.
The growth medium was yeast minimal base without amino acids and am-
monium sulphate (from Difco), as was also used by others [114]. This growth
medium contains trace elements and vitamins and it was assumed that the
uptake of the minimal components did not significantly contribute to central
metabolic fluxes or the synthesis of amino acids. The yeast minimal base
was supplemented with 5 g.L−1 ammonium sulphate as nitrogen and sulphur
source. The pH was buffered at 6.0 with 100 mM MES buffer. For growth
rate determination and measurement of external metabolite concentrations,
the medium was supplemented with 5 g/L glucose of 100 % naturally la-
belled glucose. For flux ratio analysis, the medium was supplemented with
5 g.L−1 glucose of either 100 % 1-13C glucose (99.0 % purity, from Sigma
Aldrich) or 20 % U-13C glucose (98.5 % purity, from Spectral Isotopes) plus
80% naturally labelled glucose. Culture vessels were autoclaved whereas
media was filter-sterilized with 0.22 µm pore size PES (polyethersulfone)
filters (from Millipore).
Note: The Verduyn defined minimal medium most frequently used in 13C-
MFA for yeast [113, 115] was used initially, but the yeast did not respond
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well to the medium, and very low growth rates were observed. It is sus-
pected that one of the many organic vitamin components available at the
time might have deteriorated in storage. This medium is especially diffi-
cult to work with for the anaerobic cultures, which need additional lipids
ergosterol and Tween 80 which the yeast cannot synthesize under anaerobic
conditions [115]. The lipids are not very soluble in water and the Tween 80
crystals initially forming upon addition to water will be filtered out. The
viscous Tween 80 also cannot be filter-sterilized. The best way to com-
bine the two supplements is to dissolve the ergosterol in a small amount of
ethanol and mixing it with Tween 80 which can be frozen in this way for
storage. After filter-sterilization of the other components and addition to
the culture vessels, the lipid mixture is heated to near-boiling point (which
quickly dissolves the ergosterol crystals, re-sterilizes the content and evapo-
rates the ethanol), and added directly to the medium. The latter procedure
was used by [116] for anaerobic cultivation of the yeast in a chemostat. When
using small volumes as in our study however, the lipids and water-soluble
compounds need to be first sterilized separately (with filters and heat re-
spectively), then pre-mixed and added to the vessels as such small amounts
of lipid cannot be added accurately and the viscous fluid sticks to pipettes
and filters. The need for these extra insoluble supplements in defined me-
dia makes anaerobic cultivation of yeast in small quantities laborious and
possibly inaccurate. Miniaturized flux experiments for anaerobic cultures of
yeast are also rarely seen, if ever. The use of yeast minimal base without
amino acids or ammonium sulphate was very efficient and made experiments
much easier.
5.1.2 Determination of cellular growth rate
Cell growth was followed at OD620 in a Titertek Multiskan PLUS MKII 96-
well microtiter plate spectrophotometer and microtiter plates with 300 µL
sample volume. Algorithms were implemented in Mathematica to fit expo-
nential curves through values of OD620 to obtain maximal specific growth
rates.
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5.1.3 Cellular dry weight determination
A stock of cells was grown in batch cultures and was harvested in mid-
exponential phase. For each data point, a volume corresponding to approx-
imately 100 mg of cellular dry weight was added to a membrane filter disk
with 0.22 µm pore size in a Millipore membrane filter. Membrane filter disks
were dried for 8 minutes at 330 Watt in a microwave oven and placed in a
dessicator overnight. Dried filters were immediately weighed after they were
taken out of the dessicator. The conversion factor was calculated as
c =
gdw
L
OD620
(5.1)
5.1.4 Analysis of external metabolites with HPLC
To minimize volume decrease in cell cultures due to sampling, small sam-
ples of 450 µL were taken with a pipette of which 300 µL was used for brief
OD620 determination and added again to the rest afterwards. Samples were
kept on ice during the process. Samples were centrifuged at 14 000 rpm
at 4◦C and the supernatants frozen at -80◦C for later analyses. 400 µL of
sample was treated with 24.5 µL of chilled PCA (35% m/v) and kept on
ice for 10 minutes. 22 µL of KOH (7 M) was added and kept on ice for
10 minutes. The samples were centrifuged at 14 000 rpm for 10 minutes
at 4◦C and the supernatants were kept for analysis with HPLC. The stan-
dards for HPLC analysis were glucose, ethanol, glycerol, succinate, acetate,
and pyruvate and were treated in the same way with PCA and KOH as
the samples to eliminate dilution effects. A Biorad Aminex HPX-87H ion
exclusion column for organic acids (300 mm × 7.8 mm, catalogue number
125-0140) was used at 55◦C on an Agilent 1100 Series HPLC system with a
Waters 717 autosampler, Waters 996 phosphodiode array detector (UV) and
Waters 410 differential refractometer (RI). The flow rate was 500 µL.min−1
and the mobile phase 5 mM H2SO4. Standard curves were generated for
concentrations of 2, 5, 10, 20 and 50 mM and concentrations were deter-
mined as areas under the curves in Millennium software. Glucose, ethanol
and glycerol were determined with RI detection while succinate, acetate and
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pyruvate were determined with UV detection.
5.1.5 Analysis of labelled proteinogenic amino acids with
GC-MS
The full 20 mL of cultures grown on labelled glucose cells were harvested
in early-exponential phase at biomass concentrations between 0.1 and 0.2
g.L−1 and centrifuged at 14 000 rpm at 4◦C. The pellets were washed once
with water and centrifuged. Pellets were frozen for later analyses. Cellular
pellets were hydrolyzed using 1 mL of 6 M hydrochloric acid at 110◦C in
melt-sealed glass test tubes in a dedicated hydrolysis oven. 100 µL of the
hydrolysis fluid was moved to a 1 mL flat-bottomed glass vial and the acidic
fluid removed by blowing a continuous stream of air through a pipette tip.
Immediately before derivatization, the blow-dried pellet was dried further
in an oven at 85◦C for at least 20 minutes. Derivatization was achieved
by addition of 50 µL of distilled dimethylformamide (DMFA) and 50 µL of
N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) with a
Hamilton syringe and further incubation at 85 ◦ C for 60 minutes.
Either 1 or 2 µL of the derivatized sample was injected into a Hewlett
Packard Agilent 6890N (GC) 5975 (MS) system. The GC-MS procedures
were those already described [92] except for a few changes. An Agilent
fused silica GC column with PDMS stationary phase and dimensions (60 m
× 0.32 mm × 0.25 mm) was used. The eluent gas was helium and the column
pressure was kept at 80 kPa. A split ratio of 1:20 was used. The initial oven
temperature was 150◦C and maintained for 2 min and then raised to 280◦C
at 3◦C.min−1. The GC to MS interface temperature was 250◦C, the MS ion
source temperature was 200◦C and electron impact ionization (EI) was used
at -70 eV. MS spectra were analyzed in the range of 60-650 atom mass units
at sampling intervals of 0.81 seconds per scan. A run time of 80 minutes was
needed for the long column. MS data were processed using ChemStation.
Note: Glass Hamilton syringes should be used for handling MTBSTFA as
the fumes react with polymers inside pipettes. Hydrolysis should only be car-
ried out in dedicated hydrolysis ovens as the high temperatures and strong
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acid presents a danger. Hydrolysis fluid cannot be extracted with freeze-
drying as the acid fumes can damage seals on freeze-dryers.
5.1.6 Determination of production and consumption rates of
external metabolites
Algorithms were written in Mathematica to fit exponential curves through
OD620 data to obtain the equations
Bt = (
gdw
L
)t (5.2)
by using the conversion factor of
c =
gdw
L
OD620
for each OD620 reading for both aerobic and anaerobic conditions. Curves
were also fitted through HPLC data to obtain
Mt = (
mmol metabolite
L
)t (5.3)
For concentration boundary conditions in kinetic simulations, the average
concentrations during the time before sampling for 13C analysis in GC-
MS were calculated as the integral over the time-dependent functions of
concentrations, divided by the time interval as
M¯t =
∫ tmax
t0
Mt dt
dt
(5.4)
t0 was the time at which the biomass concentration was 0.05 gdw.mL
−1
(lower accurate detection limit). At tmax the biomass concentration was
0.1 gdw.mL−1 for aerobic and 0.2 gdw.mL−1 for anaerobic cultures. The
interval between t0 and tmax was used for dt.
The total derivative of each of the time-dependent concentration equations
was normalized with the corresponding biomass concentration equations to
obtain specific production or consumption rates as functions of time
MdBt =
dMt
dt
Bt
(5.5)
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Further, the average production or consumption rates during the time before
sampling for 13C analysis in GC-MS was calculated as the integral over the
time-dependent functions of specific production or consumption, divided by
the time interval
M¯dBt =
∫ tmax
t0
MdBt dt
dt
(5.6)
This approximates the average contribution of quasi steady state external
fluxes to the labelling patterns accumulated in proteinogenic amino acids
during the time interval before the sampling of labelled amino acids.
5.1.7 Metabolic flux ratio analysis and net flux analysis
The 13C-MFA software tool FiatFlux described in [95] was kindly provided
by the authors and was used to analyze the MS spectra. The details of flux
ratio analysis were explained in Chapter 2. The program was run in the
commercial software Matlab. The necessary open source software for using
network common data format (.netCDF, exported as .AIA files) in Matlab,
mexnc and mexcdf was obtained and installed as described in the FiatFlux
software package. A 13C metabolic model of central carbon metabolism that
had been previously described [113,114](see figure 1.3) and also provided in
the FiatFlux software package (specified as mod yeast) was used unchanged,
including all specified ratios, stoichiometry and biomass requirements (see
appendix B). The metabolic flux ratios determined with the ratio.m mod-
ule was used in the netto.m module to obtain net metabolic fluxes. Mul-
tiple injections were performed from a number of samples to optimize the
derivatization protocol. For each injection, 9 independent flux ratios were
calculated. For each metabolic flux ratio, the ratio value with the smallest
associated standard deviation was used as input in the netto.m module. The
normalized, time-averaged uptake and production rates of external metabo-
lites were also used as input in the netto.m module and net fluxes were
calculated in the 13C-constrained flux balancing algorithm.
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Figure 5.1: OD620 measurements plotted against cellular dry weight con-
centrations.
5.2 Experimental results and discussion
5.2.1 Physiological characterization of Saccharomyces cere-
visiae growth on glucose
The use of small 20 mL cultures for economizing the experiments required
samples taken for monitoring of cell growth and external metabolites to be
small. The use of 620 nm instead of the conventional 600 nm was nec-
essary due to the available optical filters for the specific microtiter plate
spectrophotometer. However, the response range in the cultures at OD620
conveniently allowed plate readings without any dilutions throughout the
relevant exponential range. Figure 5.1 shows the linear response of OD620
to values of gdw.L−1. The conversion factor c was calculated to be 1.330
gdw.L−1.OD620
−1.
Figures 5.2 and 5.3 show biomass concentration increase over time. The data
corresponds well with exponential growth as can be seen in logarithmic scale
in figures 5.4 and 5.5. Maximal specific growth rates were calculated at 0.289
.h−1 for aerobic cultures and 0.343 −1 for anaerobic cultures (See table 5.1).
Anaerobic growth is usually 25 % lower than aerobic growth [117] but here
the opposite was found. The value of 0.289 .h−1 is significantly lower than
the 0.4 .h−1 found by others [113] and the reason for this is not known.
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Figure 5.2: Biomass concentrations during aerobic growth. Experiments
were performed in triplicate.
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Figure 5.3: Biomass concentrations during anaerobic growth. Experiments
were performed in triplicate.
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Figure 5.4: Estimation of maximal specific growth rate during aerobic
growth. Experiments were performed in triplicate.
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Figure 5.5: Estimation of maximal specific growth rate during anaerobic
growth. Experiments were performed in triplicate.
Table 5.1: Maximal specific growth rate (µmax) of yeast in aerobic and anaer-
obic cultures and biomass yield on glucose (YBmglc). YBmglc was calculated
as gram dry biomass produced per gram glucose consumed. Experiments
were performed in triplicate.
Aerobic growth on glucose Anaerobic growth on glucose
µmax(.h
−1) 0.289 0.343
YBmglc (gbiomass/gglucose) 0.0979 0.0782
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Table 5.2: Physiological parameters average external metabolite concentra-
tions and average external metabolite uptake and production rates deter-
mined in aerobic and anaerobic cultures. Experiments were performed in
triplicate.
Aerobic Anaerobic
Average standard Average standard
concentration deviation concentration deviation
(mM) (mM)
glucose 26.8737 0.1584 25.9258 0.5913
ethanol 5.0466 0.0870 10.8203 0.8720
glycerol 1.2104 0.03176 1.9839 0.07974
acetate 0.6437 0.01549 0.2144 0.02924
succinate 0.4105 0.002657 N.D. N.D.
pyruvate 0.04676 0.001159 0.2316 0.005389
Aerobic Anaerobic
Average standard Average standard
flux deviation flux deviation
(mmol.h−1.gDW−1) (mmol.h−1.gDW−1)
glucose -16.1024 0.4476 -23.7819 2.8424
ethanol 21.8817 0.3888 29.5872 1.1384
glycerol 4.2818 0.1108 5.3721 0.5612
acetate 1.1884 0.1844 0.7756 0.02775
succinate 0.07065 0.01458 0 N.A.
pyruvate 0.1700 0.01012 0.1571 0.02863
HPLC data of external metabolite concentrations of glucose, ethanol, glyc-
erol, succinate, acetate and pyruvate can be seen in Appendix C, figures C.1
to C.11. Note that succinate was undetectable for anaerobic conditions and
was therefore not plotted. Exponential curves could be fitted for glucose,
ethanol and glycerol with excellent correspondence for both aerobic and
anaerobic cultures. Fits through acetate, succinate and pyruvate were not
as good which was indicative of either changes in the culture or quantifica-
tion problems due to the low concentrations. Accordingly, linear equations
had to be fitted through the data points of aerobic succinate production
and anaerobic pyruvate production. For use in kinetic models, the averaged
concentration over the initial phase before 13C sampling was plotted as hor-
izontal lines over the interval, which are the values reported in table 5.2.
Time-dependent gradients of the curves were normalized with the equations
for dry weight concentration, with their averaged values over the initial
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time interval as seen in figures C.12 to C.22 in Appendix C. The uncertain-
ties involved in the apparent non-exponential production rates of acetate,
succinate and pyruvate can be seen more clearly in this representation. Re-
sults are summarized in table 5.2. The specific glucose uptake value of 16.1
mmol.h−1.gdw−1 under aerobic conditions is the same as measured by [113]
at the same pH of 6.0. Biomass yield on glucose was estimated at 0.0979
g.g−1 for aerobic conditions (See table 5.1) which is lower than the 0.16
g.g−1 found by [113]. Glycerol production was 4.28 mmol.h−1.gdw−1 which
is three times the value of 1.7 mmol.h−1.gdw−1 found by [113]. For anaero-
bic conditions, biomass yield was 0.0782 g.g−1. The slightly faster and more
wasteful anaerobic metabolism of Saccharomyces cerevisiae is apparent from
the faster glucose uptake and lower biomass yield on glucose YBmglc. Note
that the carbon balance is implicit in the 13C-constrained MFA algorithms
and that it can be accessed in the balances around each intermediate, there-
fore it is not done in the traditional way.
5.2.2 GC-MS analysis of labelling patterns in proteinogenic
amino acids.
For GC-MS analysis of 13C labelled amino acids, cells were grown either
on 100 % 1-13C glucose or a combination of 20 % U-13C glucose and 80
% glucose of natural labelling and harvested in early-exponential phase at
biomass concentrations between 0.1 and 0.2 g.L−1. After hydrolysis and
drying, the samples were derivatized with MTBSTFA and DMFA.
Figure 5.6 is a plot generated with Matlab showing the elution pattern of
amino acids in GC-MS. The longer than usual 60 m GC column provided
extremely efficient separation of the derivatized amino acids and simplified
the analyte assignment procedure, although the number of MS spectra for
each amino acid was reduced. However, this number was considered to be
sufficient for observation of labelling patterns. Figures 2.3 to 2.5 used in
Chapter 2 for explanatory purposes also originated from these experiments.
The ratio.m module of FiatFlux was used to calculate metabolic flux ratios,
as was explained in Chapter 2. Due to the use of a 60 m GC column, which
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Figure 5.6: A typical GC-MS chromatogram obtained in this study. The
aerobic or anaerobic yeast samples were hydrolyzed and derivatized with
MTBSTFA. The 60 m column provided excellent resolving power. See sec-
tion 5.1.5 for GC-MS parameters.
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is twice the length normally used for analysis in FiatFlux (as in [92]), the
default GC elution range for each amino acid was adapted. The sequence in
which derivatized amino acids eluted from the GC column was identical as
reported earlier [92]. It was found that the presence of some amino acids in
the derivatized form was insufficient for assignment. Apart from a number of
amino acids that are destroyed during acid hydrolysis (see [92]), the signals
from especially methionine, histidine and tyrosine were weak. In order to
observe all the amino acids present, we used different volumes of MTBSTFA
and DMFA in the derivatization step and injection volumes of 0.5 to 2 µL.
While overloading inevitably eliminates the use of those spectra affected
by overloading, and its inherent danger to the electron source, the use of
larger injection volumes (2 µL) and minimized volumes of the derivatiza-
tion agents enabled better observation of low concentration amino acids.
However, mostly the problems encountered with observation of amino acids
could be ascribed to the sample preparation. It was found that all sam-
ples which showed murkiness after derivatization, indicative of unsolubilized
compounds, did not contain sufficient amounts of derivatized compounds.
Subsequent addition of more MTBSTFA and DMFA to these samples and
incubation also did not solubilize and derivatize the compounds. It is thus
indicative that these samples contained a substance that caused these re-
sults.
Water could have had this effect as it is well known to influence derivati-
zation with MTBSTFA. Care was thus taken to use small volumes of the
solution of hydrolyzed cell mass and extensive drying at 85 ◦C before addi-
tion of the derivatization agent. Isotope effects were also clearly observed, as
was reported in [92]. In this phenomenon, the heavier isotopes move faster
through the GC column and thus could result in the wrong isotope ratio cal-
culation if all the MS spectra of a certain compound are not included in the
calculation. It was assumed that it was correctly interpreted in FiatFlux.
For each GC-MS analysis, FiatFlux automatically calculated independent
metabolic flux ratios from amino acid spectra. For each ratio, a standard
deviation is assigned, as was explained in Chapter 2 (see [87]). Small stan-
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Figure 5.7: Ratios from aerobic cultivation with 20 % U-13C glucose and 80
% naturally labelled glucose. 20 mL foil-capped cultures with rapid shaking
were performed in duplicate. Ratio calculations were performed in FiatFlux,
as explained in sections 5.1.7 and 2.1.
Figure 5.8: Ratio standard deviations for aerobic cultivation with 20 % U-
13C and 80 % naturally labelled glucose. Standard deviations correspond to
ratio values in figure 5.7 and were estimated as explained in section 2.1.
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Figure 5.9: Ratios from anaerobic cultivation with 20 % U-13C and 80 %
naturally labelled glucose. 20 mL nitrogen flushed cultures were performed
in triplicate, and two injections from each were used for optimizing the
derivatization protocol. Ratio calculations were performed in FiatFlux, as
explained in sections 5.1.7 and 2.1.
Figure 5.10: Ratio standard deviations for anaerobic cultivation with 20 %
U-13C and 80 % naturally labelled glucose. Standard deviations correspond
to ratio values in figure 5.9 and were estimated as explained in section 2.1.
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Figure 5.11: Ratios from aerobic cultivation with 100 % 1-13C glucose. Con-
ditions were as for figure 5.7.
Figure 5.12: Ratio standard deviations for aerobic cultivation with 100 %
1-13C glucose. Standard deviations correspond to ratio values in figure 5.11.
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Figure 5.13: Ratios from anaerobic cultivation with 100 % 1-13C glucose.
Conditions were as for figure 5.9.
Figure 5.14: Ratio standard deviations for anaerobic cultivation with 100 %
1-13C glucose. Standard deviations correspond to ratio values in figure 5.13.
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dard deviations correspond to high confidence in the measurements and the
flux model. Results are given in figures 5.7 to 5.14.
In figures 5.9 to 5.12, the results of several injections can be seen. Due to
the fact that ratios are independently calculated, for each ratio, the value
was used which had the smallest error associated with it. The independence
of ratios thus enabled the use of calculated ratios from different injections,
where each injection had theoretically the best procedures for observing the
relevant ratios, where a ratio is a function of isotope distributions of several
amino acids. This practice is however only valid if it is assumed that the ratio
with the lowest error is the one closest to theoretically perfect analysis and
that the network assumptions are correct. The network could however be
assumed as sufficient as it has been used extensively under these conditions
[114]. Further, it is apparent from the results of repetitive injections that
the ratio values which showed consistent values for all samples also had the
smallest errors associated and the highly variable ratios had the larger errors
associated. For instance, figure 5.11 and 5.12 shows this relationship clearly,
thus partly validating this practice.
Using multiple injections for each ratio is however not optimal, and will likely
be unnecessary, or greatly reduced if more time is spent on standardization
of the sample treatment setup. Only the ratios calculated previously [113]
were selected and the final values with their errors are given in table 5.3.
In general, ratios correspond well with those reported elsewhere [113]. The
ratio of approximately 90 % of the total carbon flux through the EMP
pathway is typical and is likely a ratio of high importance for integration
with a kinetic model of glycolysis. This value was found for both aerobic
and anaerobic conditions.
5.2.3 Net flux analysis with FiatFlux
Ratio values from table 5.3 and the calculated averaged external fluxes in
table 5.2 were used in the netto.m module of FiatFlux to estimate abso-
lute fluxes using the mod yeast model. The 13C-constrained flux balancing
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Table 5.3: Metabolic Flux Ratios calculated for aerobic and anaerobic cul-
tures with standard deviations.
Aerobic Anaerobic
Ratio SD Ratio SD
cytOAA form cytPYR 1.001 0.031 0.959 0.027
mOAA from anaplerosis 0.971 0.016 1.006 0.016
PEP from cytOAA 0.042 0.011 0.095 0.011
SER through glycolysis 0.899 0.011 0.921 0.011
mAcCoA from mPYR 1 1 0.346 0.106
mPYR from MAL (ub) 0.642 0.329 0.936 0.258
mPYR from MAL (lb) 0.035 0.014 0 0.015
SER from GLY 0.152 0.04 0.127 0.041
GLY from SER 0.974 0.033 0.948 0.032
algorithm repetitively converged to the solution for net fluxes as given in
table 5.4 and the balance and biomass fluxes given in table 5.5. The linear
optimization algorithm seeks to minimize the metabolite balances, using the
ratio values as extra constraints, either as specific ratio values, or as limits
for ratios. The limits are thus included not only as = constraints, but also
as ≥ and ≤ constraints which cannot be used in matrix-based analyses(see
Chapter 2, [87] and [95]). The residuals of the metabolite balances after a
conversion to a local or global minimum is then reported as the individual
metabolite balances as in table 5.5. These small balances were treated as
the fluxes of other small reactions around these metabolites and included to-
gether with biomass reactions from the same metabolites into the simulation
of the kinetic model (see Chapter 4). The optimization routine uses ran-
dom starting values where the user initializes the optimization several times
until a very small total residual (typically below 10) is achieved. For our
experiments a total residual of below 1 was achieved. Other local minima
were detected, but with much larger residuals after conversion. In particu-
lar, cycling was found between serine and glycine. This is a mathematical
artefact with a closed loop of fluxes that brings no net change [21].
In order to obtain a calculable equation set, NADH had to be balanced,
but neither did NADPH or ATP have to be balanced. An advantage of
13C-MFA is that the calculation of metabolic fluxes can be done largely in-
dependent from the assumed constraints that cofactors place on the system.
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Table 5.4: Metabolic net fluxes calculated for aerobic and anaerobic cultures
with absolute errors (95 % confidence interval).
Aerobic Anaerobic
Reaction activity reversible Flux SD Flux SD
mmol
h.gDW
mmol
h.gDW
v1glc uptake 1 0 16.104 0.448 20.694 2.843
v2PGI 1 1 13.851 0.442 18.292 2.628
v3ZWF 1 0 1.700 0.176 1.743 0.314
v4PFK 1 0 14.889 0.443 19.340 2.770
v5TKL 1 1 0.561 0.059 0.574 0.105
v6TKL 1 1 0.477 0.059 0.475 0.105
v7TAL 1 1 0.561 0.059 0.574 0.105
v8SER 1 0 0.148 0.119 0.172 0.134
v9SHM 1 0 0.115 0.140 0.127 0.154
v10SHM 1 0 0.026 0.023 0.025 0.022
v11GCV 1 1 0.003 0.118 0.007 0.133
v12TDH 1 1 25.720 0.911 33.690 5.644
v13PYR 1 0 26.680 1.000 37.025 6.253
v14PDA 1 0 0.467 1.120 0.212 1.995
v15CIT 1 0 0.420 1.018 0.549 5.763
v16ACO 1 0 0.420 1.018 0.549 5.763
v17KGD 1 0 0.131 1.021 0.202 5.764
v18SDH 1 1 0.061 1.022 0.202 5.764
v19MDH 1 1 0.012 0.030 0.000 0.038
v20FUM 1 1 0.061 1.022 0.202 5.764
v21MAE 1 0 0.049 0.992 0.202 5.801
v22PCK 1 0 1.127 0.311 3.534 0.745
v23 1 0 1.921 1.068 4.544 6.396
v24ACS 1 0 0.412 0.470 0.885 3.768
v25ALD 1 1 1.600 0.507 1.661 3.768
v26ADH 1 1 21.880 0.389 29.823 1.138
v27GPD 1 1 4.282 0.111 5.169 0.561
v28OAC 1 0 0.408 0.990 0.744 6.074
v29OAC 1 0 0.000 0.059 0.195 0.304
v30 1 0 0.000 0.467 0.393 3.769
v31 1 0 1.046 0.478 0.763 3.812
v32Atmung 1 0 0.384 2.549 0.000 12.531
v33 1 0 23.480 0.639 31.484 3.715
v34TH 0 0 0.000 0.000 0.000 0.000
growth 1 1 0.289 0.006 0.343 0.020
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Table 5.5: Metabolite balances and biomass fluxes from net flux analysis for
aerobic and anaerobic cultures.
Aerobic Anaerobic
Metabolite balanced balance to biomass balance to biomass
mmol
h.gDW
mmol
h.gDW
mmol
h.gDW
mmol
h.gDW
AcAl 1 0 0 0 0
Ace 1 0 0 0.001 0
ATP 0 15.061 3.306 17.012 3.874
C1 0 0.086 0 0.095 0
CIT 1 0 0 0 0
CO2 0 25.976 -0.526 34 -0.616
cytAcCoA 1 0 0.412 0.003 0.483
cytOAA 1 0 0.386 0.003 0.452
cytPYR 1 0 0.063 0.001 0.074
E4P 1 0 0.084 0 0.098
ethanol 1 -0.002 0 0.236 0
F6P 1 0 0 0 0
FUM 1 0 0 0 0
G6P 1 0 0.553 0.002 0.648
glucose 1 -0.001 0 3.088 0
GLY 1 0 0.092 0 0.108
glycerol 1 0 0 -0.203 0
mitAcCoA 1 0 0.047 0 0.055
MAL 1 0 0 0 0
mitOAA 1 0 0 0 0
mitPYR 1 0 0.628 0.008 0.736
NADH 1 0 -0.062 0 -0.073
NADPH 0 1.791 3.256 1.485 3.816
O2 0 -0.384 0 0 0
OGA 1 0 0.288 0.005 0.338
P5P 1 0 0.102 0 0.119
PEP 1 0 0.168 0.001 0.196
S7P 1 0 0 0 0
SER 1 0 0.059 0 0.069
SUCC 1 0 0 0 0
T3P 1 0 0.105 0 0.123
GROWTH 1 0 -0.289 0.004 -0.339
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Cofactors, especially ATP are used in multiple reactions and with unknown
stoichiometry, which would introduce a lot of uncertainty to the calculation
of fluxes. Also was balancing of one-carbon units (C1), carbon dioxide and
oxygen not necessary. The large balances for ATP and NADPH are thus not
due to small unknown reactions, but were interpreted as their calculated net
consumption rates due to a multitude of reactions outside the flux model.
It was concluded that the FiatFlux software was user friendly and the au-
tomated layout of the program was especially well-designed for processing
multiple datasets. A few minor problems were encountered with reports to
.xls format in netto.m of FiatFlux version 1.5. Further, the netto.m did not
detect the flux model used in the ratio.m module automatically. The origins
were detected and the code adjusted for our own use.
Chapter 6
Flux-constrained simulation
6.1 Details of the simulation
The flux-constrained methodology was put to the test by using the results
of our experiments. The experimental procedures were discussed in Chapter
5 and results were given in tables 5.4 and 5.5. The big question was whether
the kinetic model of Teusink, which had been constructed for a different
strain (industrial Koningsgist) could be used to describe metabolism in the
strain CEN.PK 113-7D, using the same enzyme parameters. Further, maxi-
mal enzyme activities (Vmax) were not measured in our study. Vmax values
can be expected to vary between different strains and conditions, therefore
they will inevitably have to be measured. It can be expected however, that
other enzyme parameters should not change as significantly as Vmax val-
ues. Also, concentrations of metabolites were not measured, therefore the
pool sizes of conserved moieties were taken to be the same as in the original
model. Very important for this study would be that parameters should not
be fitted to obtain simulation results that represent the physiological data,
as is frequently encountered in the literature. The essential difference is here
that the mechanistic in vitro measurements are tested.
Our software program, Kinomics, was used to integrate the kinetic model
from the JWS with the net fluxes, balance fluxes and biomass fluxes obtained
for aerobic and anaerobic conditions. The measured concentrations of ex-
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tracellular glucose, ethanol and glycerol from table 5.2 were used as fixed
concentration boundary conditions, whereas external succinate, acetate and
pyruvate concentrations do not feature in the kinetic model.
The robustness that the program provides enables one to extract the most
realistic parts of a kinetic model, while less realistic parts can be replaced ei-
ther by flux and concentration measurements, or more realistic models. The
Teusink model features many realistic mechanistic expressions for enzyme
reactions, with a few reactions of either flux data values or phenomeno-
logical expressions. The two branch reactions for glycogen and trehalose
synthesis from glucose-6-phosphate had originally been modelled by the au-
thors as constant measured boundary reactions, as is proposed for a wider
application in this thesis. Also, phenomenological rate equations for succi-
nate synthesis and ATP consumption were included as first order kinetics
responding to their substrates succinate and ATP. The origin of succinate
was unknown in that study, therefore it was assumed that it was derived
through the glyoxylate cycle. The succinate producing rate equation was
made responsive to only acetaldehyde, but acetaldehyde, NAD and ADP
were consumed, while succinate, NADH and ATP was produced. A general
ATPase was also included to describe all other reactions that consume ATP,
such as biomass requirements and maintenance.
We can now measure metabolic fluxes more accurately by combining known
biomass requirements with 13C isotope labelling experiments and thus elu-
cidate the source of the succinate and more accurately calculate the ATP
consumption flux. The context dependent rate equations for glycogen, tre-
halose, succinate and ATPase could thus be replaced with their accurately
measured fluxes, while still using the detailed enzyme kinetics of the other re-
actions. The stoichiometry of the succinate reaction vSuc was thus replaced
by the larger network stoichiometry, which did not feature the glyoxylate
cycle, as was validated for these conditions in [114]. It is thus a case of
replacing context dependent reaction blocks with measured reaction fluxes
for the reference condition, while conserving detailed parts.
The ATPase in the kinetic model (vATP) was set to zero with manual
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transforms, as the boundary reactions that use and produce ATP (measured
fluxes, biomass fluxes and balance fluxes) account for the ATPase. The
glycogen and trehalose producing reactions vGLYCO and vTreha were also
set to zero as the biomass reactions that consume G6P account for the
storage metabolites produced from G6P. Likewise, vSuc was also set to zero.
The first assessment of the performance of the kinetic model was to see
whether a steady state was reached upon numerical simulation. The algo-
rithms described in Chapter 4 were used to obtain the conserved moieties in
the kinetic model. Conserved concentration moieties existed for the adenines
Adenines = ATP +ADP +AMP (6.1)
and the nocotinamides
Nicotinamides = NADH +NAD+ (6.2)
To fulfil the concentration moiety constraints, the same values for the con-
stituents were used as initial values as was found for the model in the JWS.
The moiety balance checking algorithm was used to make sure that the net
constraints on the moieties were exactly zero.
First, simulations were carried out without setting of kinetic model pathway
fluxes with setfluxes (see Chapter 4). No steady state was reached as there
was a continued increase in the F16BP concentration.
6.2 Investigating the cause of model behaviour
It was investigated whether the values used to convert the values from 13C-
constrained flux analysis (mmol.h−1.gdw−1) to the units used for kinetic
modelling (mmol.min−1.L−1) could have been the cause of an overly con-
strained system of rate equations. Here gdw is for the number of grams total
cellular dry weight in an amount of cells, and gprot is the number of grams
of total cellular protein in an amount of cells. L is the number of litres of
intracellular water in an amount of cells. The conversion was calculated as
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follows:
mmol
min L
= (
mmol
h gdw
)(
h
min
)(
gdw
gprot
)(
gprot
L
) (6.3)
where the value
L
gprot
= 0.00375
was also used in the original model for calculations [44]. The value
gprot
gdw
= 0.5
is typically used for yeast, but values could vary from 0.243 to 0.497 for
aerobic cultivation and from 0.254 to 0.559 for anaerobic cultivation. These
estimations were carried out in chemostats under various conditions of car-
bon to nitrogen limitation, with or without addition of benzoic acid [118].
The values of 0.5 gprot.gdw−1 and 0.00375 L.gprot−1 leads to a conversion
factor of
(
1
60
)(
1
0.5
)(
1
0.00375
) = 8.89
and thus a glucose uptake flux in aerobic cultures of
(16.104)(8.89) = 143.17
mmol
min L
and
(20.694)(8.89) = 183.97
mmol
min L
for the anaerobic cultures. These values are significantly higher than the
108 mmol.min−1.L−1 observed in the glucose runout experiments for initial
validation of the kinetic model [44]. This finding, but more so, the uncer-
tainties involved with the values for L.gprot−1 and gprot.gdw−1 indicated
that we should focus more on these parameters. Thus, the conversion factor
was varied over a wide range to test whether a steady state was reachable.
Only a decrease by a factor of ten allowed conversion to a steady state. This
observation indicated that a steady state was possible, and that the inte-
grated structure is not erroneous from a structural perspective. A ten-fold
error in the conversion factor is rather unlikely though, and other possible
sources of error were investigated.
The comprehensive comparative output .xls spreadsheets were used to anal-
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Table 6.1: Maximal activity values compared to metabolic net fluxes in
aerobic and anaerobic cultures.
Vmax MFA Aerobic Anaerobic
reaction flux flux
V max
flux flux
V max
VmGLT 97.26 Measv1glcuptake 143.16 1.47 183.97 1.89
VmGLK 226.45 Measv1glcuptake 143.16 0.63 183.97 0.81
VmPGI 339.68 Measv2PGI 123.14 0.36 162.62 0.48
VmPFK 182.90 Measv4PFK 132.36 0.72 171.93 0.94
VmALD 322.26 Measv4PFK 132.36 0.41 171.93 0.53
VmG3PDH 70.15 Measv27GPD 38.07 0.54 45.95 0.66
VmPGM 2525.81 Measv12TDH 228.65 0.09 299.50 0.12
VmENO 365.81 Measv12TDH 228.65 0.63 299.50 0.82
VmPYK 1088.71 Measv13PYR 237.19 0.22 329.15 0.30
VmPDC 174.19 Measv33 208.74 1.20 279.89 1.61
VmADH 810.00 Measv26ADH 194.51 0.24 265.13 0.33
VmGAPDHf 1184.52 Measv12TDH + Measv8SER 229.96 0.19 301.02 0.25
VmPGK 1306.45 Measv12TDH + Measv8SER 229.96 0.18 301.02 0.23
yse firstly whether the maximal activity values in the model allowed a steady
state comparable to the measured fluxes. Indeed, the maximal activities of
the glucose transporter vGLT and pyruvate decarboxylase vPDC were too
low to sustain the measured fluxes (table 6.1). Further, a number of other
Vmax values were very close to the measured fluxes, indicating that even
with very low concentrations of their products, the forward reactions could
hardly produce the measured fluxes and it is likely that their substrates
would build up to high levels.
The next step would be to either measure maximal activities of the enzymes
for this strain and conditions or obtain more realistic values from the liter-
ature. Further analysis without this research would be futile in principle.
We thus chose not to fit maximal activity values because then we would lose
the context independence of the modelling process. The conversion factors
also need more attention. This would likely involve measurement of cellular
protein concentrations, while the amount of cell water per unit of protein
is more difficult to measure and would likely be taken from the literature.
Further, as flux experiments have a limited capacity for model accuracy as-
sessment, a technology driven approach of metabolomics is needed to work in
combination with flux measurements. Just like flux measurements, concen-
tration measurements are essential as boundary values and for validation,
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but also for inputs as moiety pool sizes. Only with this in place can we
proceed with the protocol of localized validation with isotope labelling and
metabolomics, as was introduced in Chapter 3.
Chapter 7
Discussion and conclusion
Genome-scale kinetic modelling is seen as a powerful method for making
sense of biochemical phenomena. These models can give deep insight into the
regulation of cellular processes. Unfortunately, the parameters for detailed
kinetic models are difficult to obtain, which limits both their size and the
confidence in their predictions. Alternatively, stoichiometric models can be
created at the genome scale. Frameworks for their analyses such as FBA [14]
and advanced optimization programs [22] have been developed. Analysis of
stoichiometric models with FBA lacks in the fact that it does not incorporate
the nonlinear behaviour of biochemical systems. Nonlinear behaviour can
only be captured with kinetic models, which incorporate the concentrations
of metabolic species as variables. It might seem an obvious solution for the
near future to combine large stoichiometric models with kinetic models in
some way.
The approach taken here was to use a large structural model, not for in-
creasing the scope of predictions by including a wider metabolic network,
but as a flux data model that facilitates validation of kinetic parts. The work
described here is a part of the Silicon Cell Initiative, aimed at a parts-based
genome-scale kinetic description of the yeast. The idea is to eventually create
the whole from kinetic parts, built ’on top of’ a genome-scale pathway map.
Extensive accuracy assessments of these detailed parts are necessary before
they can be linked. Apart from the general idea of combining structural
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and kinetic models, two more direct aims were identified for this project,
namely:
1. To learn the techniques in 13C-MFA.
2. To investigate how the boundary reactions should be incorporated for
steady state kinetic modelling.
Chapter 3 explained why it is important to include measured boundary flux
data for validation. It is both necessary for putting the correct constraints
on the kinetic parts (from there the name flux-constrained simulation) and
can be used for direct comparison. A generic theoretical approach was fol-
lowed for incorporating boundary fluxes and a number of implications were
discussed in Chapter 3.
It was explained that boundary fluxes alter MCA predictions, but that they
have to be included in an MCA algorithm, as they are necessary to ob-
tain accurate steady state simulations. Suggestions were made to design an
MCA algorithm that incorporates uncertainties of kinetics at the boundary
reactions, which would resemble an existing formalism [63] to an extent.
The many variables in a kinetic model and its integrated nature make it dif-
ficult to locate dubious parameters. It was argued that flux relations create
a large degree of redundancy in the data, decreasing the validation poten-
tial of flux data. Also, rate equations have maximal activity values which
put further constraints to the simulated values, and make falsely accurate
simulations more likely. Rather, the validation criteria should rely more on
metabolomics data, where the measured fluxes should be used as inputs in
some way. It was shown how this can be done by setting pathway fluxes to
measured values. A certain number of fluxes can be set, whereas additional
settings will cause an artefact. There are limitations to his approach, as
was pointed out. Not all pathways can be set to measured fluxes. Further,
the integrated nature of a kinetic system makes it likely that the dubious
parameters cannot be located. Others have separated kinetic systems into
smaller subsystems to fit parameters in a more local fashion on time series
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data [52]. Our objective was to develop a similar idea for local accuracy as-
sessment on flux data. Fluxes through small kinetic subsystems can always
be set to measured values. The idea is flexible with a number of criteria
with regard to the availability and accuracy of metabolomics data.
Moiety constraints have implications for the use of boundary fluxes. The
summed boundary fluxes acting on one moiety must equal zero, otherwise a
steady state cannot be reached. They also cannot be left out, for they have
an effect on the interconversion in moieties. Others have described how moi-
eties are correctly modelled [51, 101], where the total moiety concentration
has to be measured, but they have not discussed whether the inclusion of
measured fluxes alter this need for data. From structural analysis it might
seem obvious that these boundary fluxes eliminate the moiety. However,
the fact that these boundary flux values must always cancel out around the
moiety, implicates that the moiety is still a feature of the kinetic simulation.
It inevitably means that the total moiety concentration has to be measured.
Validation on steady state flux and concentration data is limited due to the
fact that only a few data points are used to link measured values to enzyme
parameters. Dynamic pulse experiments which produce time series data
will be a main feature in the validation procedure of the Silicon Cell. These
experiments have their own technical challenges at this stage, but they are
being solved by advances in analytical technologies. Of more importance
for this discussion is that a number of fundamental problems with pulse
experiments limit the information that they can provide. Even with the
best analytical technologies these problems will be present. Of note is that
the reversibility of enzyme reactions results in too many enzyme parameters
to observe for the number of variables measured. With regard to this, it
was pointed out that 13C-MFA has the potential to simultaneously provide
forward and reverse fluxes. It can thus limit the feasible parameters further
than net fluxes can. It was proposed that isotope labelling in both steady
state metabolomics and dynamics pulse experiments will be very important
for detailed kinetic modelling in the future.
To summarize, this chapter gave and elaborate discussion on the inclusion
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of boundary fluxes into kinetic simulations. The second of the two aims
were thus met. A venture was taken into the validation potential of flux
data. It was explained that fluxes have fundamental limits in its validation
potential, but that it still has high value, especially in the view that it can
complement dynamic pulse experiments.
Based on our findings in Chapter 3, a simulation program was designed
which allows for robust flux-constrained simulation. The program, called
Kinomics, was described in Chapter 4. It has proven very useful thus far,
although it is still rather rudimentary. It was proposed how the program
will be extended for easier use and to incorporate more functionality related
with bioinformatics. Although there are a number of excellent standalone
simulation programs in the literature [107–112], this program seems to be
unique in allowing robust connection between kinetic models and stoichio-
metric models.
To illustrate our approach we measured metabolic fluxes in the yeast at a
quasi steady state with 13C-constrained flux balancing, using GC-MS and
the flux analysis program FiatFlux. The experimental procedures have been
well-defined by others such as the group of Sauer [113], which made the work
manageable in the time scale of the project. Results were given in Chapter 5.
Valuable experience has been gained with the techniques and theory behind
13C-MFA, which are new to our research group. The knowledge obtained
which was briefly outlined in Chapter 2, together with the good quality of
the data suggest that the first of our two aims has also been achieved.
Our program was then used to constrain a detailed kinetic model of yeast
glycolysis [44] with the flux data from our experiments (Chapter 6). The
less detailed and context dependent reactions in the kinetic model were
replaced by accurate flux measurements to assess the accuracy of simulation
results. The question was whether the in vitro kinetics of the Teusink model,
which was constructed for a different strain and conditions, could be used
to describe the flux data in our experiments. Early on it was found that no
steady state was reached in the simulations. A closer investigation showed
that in principle, steady states of the flux data could not be reached as
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several maximal activity values were too low to support the fluxes. This was
not seen as a defeat, as our approach already showed the first errors in the
model - the maximal activity values need measurement at these conditions.
By not fitting enzyme parameters to the data, the context independent
mechanistic approach was followed strictly, which is the basis for further
work.
Appendix A
Rate equations
vGLT→
(
GLCo− GLCiKeqGLT
)
VmGLT
/
(
1 + GLCiKmGLTGLCi +
GLCo
KmGLTGLCo +
αGLCiGLCo
KmGLTGLCiKmGLTGLCo
)
KmGLTGLCo
vGLT→
(GLCo− GLCiKeqGLT )VmGLT
(1+ GLCiKmGLTGLCi+
GLCo
KmGLTGLCo
+ αGLCiGLCo
KmGLTGLCiKmGLTGLCo )KmGLTGLCo
vGLK→
(ATPGLCi−ADPG6PKeqGLK )VmGLK
(1+ ADPKmGLKADP+
ATP
KmGLKATP)KmGLKATP(1+
G6P
KmGLKG6P
+ GLCi
KmGLKGLCi)KmGLKGLCi
vPGI→
(G6P− F6PKeqPGI )VmPGI
(1+ F6PKmPGIF6P+
G6P
KmPGIG6P )KmPGIG6P
vGLYCO→ KGLYCOGEN
vTreha→ KTREHALOSE
vPFK→ ATPF6PgR
(
1 + ATPKmPFKATP +
F6P
KmPFKF6P +
ATPF6PgR
KmPFKATPKmPFKF6P
)
VmPFK
/
(
KmPFKATPKmPFKF6P
(
1 + ATPKmPFKATP +
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KmPFKF6P +
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KmPFKATPKmPFKF6P
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+
(1+ATPCiPFKATPKiPFKATP )
2(1+ATPCPFKATPKmPFKATP )
2

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ATPKPFKAMP
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CPFKF26BPF26BP
KPFKF26BP )
2
L0
(1+ ATPKiPFKATP)
2

1+ ADP
2KeqAK
ATPKPFKAMP
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2
)
vALD→
(
F16P− KeqTPITRIO
2
KeqALD(1+KeqTPI)2
)
VmALD
/
(
KmALDF16P
(
1 + F16PKmALDF16P +
TRIO
(1+KeqTPI)KmALDDHAP +
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(1+KeqTPI)KmALDGAP+
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(1+KeqTPI)KmALDF16PKmALDGAPi +
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(1+KeqTPI)2KmALDDHAPKmALDGAP
))
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vG3PDH→
(
−
GLYNAD
KeqG3PDH +
NADHTRIO
1+KeqTPI
)
VmG3PDH
/
(
KmG3PDHDHAPKmG3PDHNADH
(
1 + NADKmG3PDHNAD +
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KmG3PDHNADH
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(
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vPGK→ (ADPBPGKeqPGK−ATPP3G)VmPGK
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KmPGKBPG
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KmPGKP3G )
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(− P2GKeqPGM+P3G)VmPGM
KmPGMP3G(1+ P2GKmPGMP2G+
P3G
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KmENOP2G(1+ P2GKmENOP2G+
PEP
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vPYK→
(ADPPEP−ATPPYRKeqPYK )VmPYK
KmPYKADP(1+ ADPKmPYKADP+
ATP
KmPYKATP)KmPYKPEP(1+
PEP
KmPYKPEP
+ PYR
KmPYKPYR )
vPDC→ KmPDCPYR
−nPDCPYRnPDCVmPDC
1+KmPDCPYR−nPDCPYRnPDC
vSUC→ ACEKSUCC
vADH→ −
(
ETOHNAD− ACENADHKeqADH
)
VmADH
/
(
KiADHNADKmADHETOH
(
1 + ETOHKmADHNADKiADHNADKmADHETOH +
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KiADHNADHKmADHACE+
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))
vATP→ ATPKATPASE
vAK→
(
ADP2 − AMPATPKeqAK
)
VmAK
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13C-metabolic model
reactions
v1glc uptake: glucose + ATP > G6P
v2PGI: G6P = F6P
v3ZWF: G6P > P5P + 2 * NADPH + CO2
v4PFK: F6P + ATP > 2 * T3P
v5TKL: 2*P5P = S7P + T3P
v6TKL: P5P + E4P = F6P + T3P
v7TAL: S7P + T3P = E4P + F6P
v8SER: T3P > SER + NADH
v9SHM: SER + NADH > GLY + C1
v10SHM: GLY + C1 > SER + NADH
v11GCV: C1 + CO2 + NADH = GLY
v12TDH: T3P = PEP + ATP + NADH
v13PYR: PEP > cytPYR + ATP
v14PDA: mPYR > mAcCoA + CO2 + NADH
v15CIT: mOAA + mAcCoA > CIT
v16ACO: CIT > OGA + CO2 + NADH
v17KGD: OGA > SUCC + CO2 + 0.5*ATP + NADH
v18SDH: SUCC = FUM + NADH
v19MDH: MAL = mOAA + NADH
v20FUM: FUM = MAL
v21MAE: MAL > mPYR + CO2 + NADPH
v22PCK: cytOAA + ATP > PEP + CO2
v23: cytPYR + CO2 + ATP > cytOAA
v24ACS: acetate + 2 * ATP > cytAcCoA
v25ALD: acetaldehyde = acetate + NADPH
v26ADH: acetaldehyde + NADH = ethanol
v27GPD: T3P + NADH = glycerol
v28OAC: cytOAA > mOAA
v29OAC: mOAA > cytOAA
v30: cytAcCoA > mAcCoA
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v31: cytPYR > mPYR
v32Atmung:O2 + 2*NADH > 2*PO*ATP
v33: cytPYR > acetaldehyde + CO2
v34TH: NADPH > NADH
ratios
cytOAA from cytPYR = [v23]/([v29OAC]+[v23])
mOAA from anaplerosis = [v28OAC]/([v19MDH]+[v28OAC])
PEP from cytOAA = [v22PCK]/([v22PCK]+[v12TDH])
SER from glycolysis = (2*[v4PFK]-2*[v6TKL]-2*[v7TAL])/
(2*[v4PFK]+[v5TKL]+[v6TKL])
mAcCoA from mPYR = [v14PDA]/([v14PDA]+[v30])
mPYR from MAL (ub) ≥ [v21MAE]/([v31]+[v21MAE])
mPYR from MAL (lb) ≤ [v21MAE]/([v31]+[v21MAE])
SER from GLY = [v10SHM]/([v10SHM]+[v8SER])
GLY from SER = [v9SHM]/([v11GCV]+[v9SHM])
biomass
(0.438)*(237*[P5P]+140*[T3P]+660*[E4P]+1321*[PEP]+
2546*[cytOAA]+463*[SER]+726*[GLY]+371*[cytAcCoA]+
2085*[OGA]+4952*[mPYR]+371*[mAcCoA]-3599*[CO2]+
17546*[NADPH]-1393*[NADH]+10293.2*[ATP])
1*(234*[P5P]+142*[T3P]+101*[cytOAA]+142*[CO2]+
449*[NADPH]+528*[NADH]+2527*[ATP])
1*(13.04*[P5P]+6.52*[T3P]+6.52*[cytOAA]+6.52*[CO2]+
23.28*[NADPH]-42.84*[NADH]+151.868*[ATP])
1*(153.44*[T3P]+217.35*[cytPYR]+109.27*[cytOAA]+
1260.49*[cytAcCoA]-388.64*[CO2]+3007.9*[NADPH]-
90.44*[NADH]+1776.81*[ATP])
1*(1911*[G6P]+2123*[ATP])
1*(83.3*[OGA]+83.3*[NADPH]+333*[ATP])
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Fermentation data plots
Note: All experiments were performed in triplicate. Procedures were as given in
section 5.2.1.
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Figure C.1: Glucose concentrations during aerobic growth.
118
Appendix C. Fermentation data plots 119
1 2 3 4 5
time HhoursL
5
10
15
20
25
30
35
concentration HmmolLL
Figure C.2: Glucose concentrations during anaerobic growth.
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Figure C.3: Ethanol concentrations during aerobic growth.
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Figure C.4: Ethanol concentrations during anaerobic growth.
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Figure C.5: Glycerol concentrations during aerobic growth.
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Figure C.6: Glycerol concentrations during anaerobic growth.
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Figure C.7: Acetate concentrations during aerobic growth.
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Figure C.8: Acetate concentrations during anaerobic growth.
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Figure C.9: Succinate concentrations during aerobic growth.
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Figure C.10: Pyruvate concentrations during aerobic growth.
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Figure C.11: Pyruvate concentrations during anaerobic growth.
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Figure C.12: Glucose consumption during aerobic growth.
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Figure C.13: Glucose consumption during anaerobic growth.
Appendix C. Fermentation data plots 123
1 2 3 4 5 6
time HhoursL
5
10
15
20
25
30
35
40
external flux HmmolHh gDWL L
Figure C.14: Ethanol production during aerobic growth.
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Figure C.15: Ethanol production during anaerobic growth.
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Figure C.16: Glycerol production during aerobic growth.
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Figure C.17: Glycerol production during anaerobic growth.
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Figure C.18: Acetate production during aerobic growth.
1 2 3 4 5
time HhoursL
0.25
0.5
0.75
1
1.25
1.5
1.75
2
external flux HmmolHh gDWL L
Figure C.19: Acetate production during anaerobic growth.
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Figure C.20: Succinate production during aerobic growth.
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Figure C.21: Pyruvate production during aerobic growth.
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Figure C.22: Pyruvate production during anaerobic growth.
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